University of Memphis

University of Memphis Digital Commons
Electronic Theses and Dissertations
7-21-2015

Statistical Shrinkage Methods for Classification, Prediction, and
Feature Extraction Using Genomewide Gene Expression Data and
Small Sample Sizes
Behrouz Madahian

Follow this and additional works at: https://digitalcommons.memphis.edu/etd

Recommended Citation
Madahian, Behrouz, "Statistical Shrinkage Methods for Classification, Prediction, and Feature Extraction
Using Genomewide Gene Expression Data and Small Sample Sizes" (2015). Electronic Theses and
Dissertations. 1204.
https://digitalcommons.memphis.edu/etd/1204

This Dissertation is brought to you for free and open access by University of Memphis Digital Commons. It has
been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of University of
Memphis Digital Commons. For more information, please contact khggerty@memphis.edu.

STATISTICAL SHRINKAGE METHODS FOR CLASSIFICATION, PREDICTION,
AND FEATURE EXTRACTION USING GENOMEWIDE GENE EXPRESSION
DATA AND SMALL SAMPLE SIZES
by
Behrouz Madahian

A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy

Major: Mathematical Sciences

The University of Memphis
August 2015

Acknowledgements

I Would like to take this opportunity to thank those who made this thesis
possible. First of all, I want to thank you my advisor Dr. Lih Yuan Deng for his
excellent guidance and persistent patience toward me during my PhD at
University of Memphis. The confidence he put in me has been extremely
important to complete my studies. He has always been readily available for my
many questions which have guided my studies. I am also extremely grateful to my
supervisor Dr. Ramin Homayouni. I had the honor of working with Dr. Ramin
Homayouni for the last 5 years from the time I started my Masters in
Bioinformatics. He has always given me freedom to explore new ideas, learn new
techniques, and taught me how to think critically and work across
multi-disciplinary frameworks which helped me mature quickly. I am extremely
fortunate to have him as my mentor. His highly dynamic research team has
helped me deepen my knowledge and experience in several different areas of
research and expertise. His continual support and encouragement helped me
through my studies. I would also like to thank Dr. Dale Bowman, Dr. Hongmei
Zhang and Dr. Su Chen for serving as my committee members and for their
valuable comments and suggestions. I would like to thank all instructors in the
division of Statistics for offering very valuable courses making learning enjoyable.
I would also like to thank my family for supporting me in my studies which without
their help this work was not possible.

ii

Abstract

Madahian, Behrouz. PhD. The University of Memphis. August, 2015. Statistical
Shrinkage Methods for Classification, Prediction, and Feature Extraction Using
Genomewide Gene Expression Data and Small Sample Sizes. Major Professor:
Dr. Lih Yuan Deng.

With advent of new technologies, more data is being collected than ever
before. Data is pouring in from every conceivable direction: from operational and
transactional systems, from Micro array experiments and Genome Wide
Association Studies, from inbound and outbound customer contact points, from
mobile media and the Web to mention a few. Researchers and investigators in
many fields are faced with the problem of identifying important effects among
thousands of variables in high dimensional datasets. This process often results in
non or weekly identified effects. Nowadays a common problem when processing
data sets with large number of variables compared to small sample sizes is to
estimate the parameters associated with each variable. When the number of
variables far exceeds the number of samples, the parameter estimation becomes
very difficult. The attempt to find important variables deriving different phenomena
based on single variable analysis is more likely to not give a comprehensive
picture due to complexity of the phenomena and presence of several predictors
with potentially significant effects. Thus, methods based on single variable
analysis are too simple to give a comprehensive picture of phenotype
architecture. Therefore, more statistically challenging models which are able to
accommodate simultaneous analysis of a large number of variables despite small
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sample sizes are essential in these cohorts. In this thesis, we developed several
novel methods for sample classification, prediction and feature extraction in
cohorts with large number of variables compared to small sample sizes using
Bayesian shrinkage methods as well as non-parametric methods such as Support
Vector Machines and Random Forests. We utilized Generalized Double Pareto
and Double Exponential prior distributions on parameters in Bayesian Generalized
Linear Models setting. These distributions have a spike at zero shrinking the
parameters towards zero which imposes sparsity in the model. We utilized
Markov Chain Monte Carlo (MCMC) method based on Gibbs sampling algorithm
to estimate the parameters. The models were applied to Microarray data sets
such as prostate cancer, leukemia, and breast cancer cohorts. In order to obtain
more robust results 50 resampling on train and test data was performed and
average performance of the models in 50 runs were reported. We investigated the
classification accuracy, feature extraction ability, and prediction ability of the
models. Based on our findings, the Bayesian hierarchical models developed
obtain high classification accuracy as well as result in more cohesive variable sets
compared to other common methods used for the same purpose. We show that
using few predictors obtained from our models, we achieve higher performance
compared to other competitive methods. We also investigated the use of literature
to aid the selection of initial predictors used in the model. Our finding suggests
that even though in some instances use of literature will result in better prediction
and classification, this is not unanimously true and in some cases it results in
poorer performance. This is mainly due to the fact that literature based predictor
iv

sets can be weak signals in the data set at hand as well as our information about
the variables deriving different phenomena based on literature is not fully
complete. Ideally, we would like to use literature to tune and prioritize signals
directly coming from the experiment. To this end, we developed a literature aided
sparse Bayesian Generalized linear model that uses literature information a priori
to guide the choice of hyper parameters and amount of shrinkage imposed in the
model. The developed model not only achieves high classification accuracy,
sensitivity, and specificity but also, results is substantially more relevant genesets
which turns out to explain the underlying mechanisms of phetotypes better.
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Chapter 1
Introduction
The hereditary material in humans and almost all other organisms is stored in
DNA or deoxyribonucleic acid [2]. Four basic molecular units called nucleotides
form linear double-stranded polymer called DNA. These four base pairs are
adenine, thymine, cytosine, and guanine. For simplicity they are called A, T, C,
and G bases respectively. DNA bases pair up with each other with strict base
pairing rule: A pairs with T with 2 hydrogen bonds and C pairs with G with 3
hydrogen bonds. Genetic information is stored in sequence of nucleotides. Genes
are specific sequences of DNA that provide instructions for several activities in the
cells. The coding parts of DNA sequence determine what the purpose of the gene
is and the non-coding sequence determines when the gene is expressed. When a
gene becomes active, in a process called transcription an RNA copy of the gene’s
information is created. In RNA the 3 base pairs A,C,G are the same as the ones
in DNA and instead of T it has Uracil (U). In RNA, A pairs with U and C pairs with
G as in DNA. RNA molecule has 3 different types:
• Messenger RNA (mRNA): it contains genetic information needed to make
proteins.
• Transfer RNA (tRNA): performs a role in protein production in the cell by
transferring protein building block (amino acids) to the protein synthesis
machinery.
• Ribosomal RNA (rRNA): it is the RNA component of ribosome (protein
synthetic machinery).
1

The process of conversion from mRNA to protein is called translation. The
abundance of corresponding RNA for each gene determines the levels of gene
expression which is generally an indicator of the amount of protein produced [22].
Since not all the genes are active at the same time, the study of expressed genes
under different conditions such as different cancers or treatment has proved to be
very effective in casting light on gene disease associations.
DNA Microarray
DNA microarray technology enables scientist to examine several thousands
of genes at the same time. A microarray is made up of thousands of precisely
placed nucleotides called probes on a small piece of glass. Each probe contains
different DNA oligonucleotide sequence that is complementary to the mRNA of
interest. The DNA oligonucleotide is immobilized on the microarray surface using
photolithography or spotting techniques. Generally, mRNA is reverse transcribed
to generate a more stable molecule called complementary DNA or cDNA. After
this process is done, the cDNA molecules are labeled with fluorescents dyes. The
cDNA molecules bind to the probes that are complementary to their sequence by
hydrogen bonds. Then the array is washed and scanned by confocal scanners.
The intensity of the lights emitted is used to determine the amounts of mRNA
which is the surrogate to the gene expression values and the amount of proteins
produced.
Proteins (such as enzymes, hormone receptors to mention a few) are
functional units of cells. Some examples of cellular activities performed by
proteins includes but are not limited to cell differentiation, response to
2

environmental stimuli, cell division (mitosis), and cell death (apoptosis). Since
proteins are functional machinery of the cells and the amount and type of the
proteins produced in the cells are determined by the genotype of the cell,
expression of genes determine the phenotypes of cells and organisms. That
means that different organisms and tissues can perform their specific functions
through expression of different genes.
Using DNA Microarray to Help Diagnostics and Therapeutics
DNA Microarray provides facilities for researchers to learn more about
different types of diseases such as study of cancer. In the past, scientists have
classified different types of cancers based on the morphology of the organs in
which the tumor develops. Microarray technology provides invaluable means for
studying diseases based on patterns of gene expression in tumor cells which has
opened new channels for diagnostics and innovative therapeutics. By using
microarrays, design of targeted treatment strategies towards specific types of
cancers has become possible. Furthermore, by examining the gene activity
differences in normal and tumor cells, treated and untreated tumor cells, scientists
will be able to understand exactly how different therapies affect tumors which
potentially can lead to more effective treatments.
Gene Expression Analysis
One of the most important applications of DNA Microarrays is based on
gene expression analysis. Estimation of the level of expression of several
thousands of genes for the sample of cells have been made possible by the use of
DNA microarrays. In gene expression analysis, molecular signature of the tissue
3

is obtained by allowing the RNA obtained from the tissue hybridize on the DNA
Microarray. This information may help to perform better disease classification,
guide choice of therapy, and identify new therapeutic targets.
Sample Classification Based on Gene Expression Analysis
The classification of different tumor types is of major importance in cancer
diagnostics and new therapeutic discoveries [2, 3, 71]. A disease like cancer is
fundamentally a malfunction of genes [3]. It is known that cancer classification
based on gene expression data provides the key information for addressing
fundamental problems pertaining to diagnostics of cancer and discovery of new
drugs. Diagnostics and discrimination of sample types based on gene expression
data has the potential to provide reliable and accurate cancer classification. Many
studies have shown the superior diagnostic performance of cancer classification
based on gene expression data compared to traditional methods based on
morphology and clinical appearance [79, 80, 100, 105].
A variety of techniques have been developed which utilize gene expression
data for cancer classification. Some of these methods include but are not limited
to Bayesian analysis [16, 59], support vector machine (SVM) [36, 84, 92],
self-organizing maps [63], k-nearest neighbor (KNN) [77, 106], and ensemble
methods [44, 83]. Most of these methods are based on selecting a subset of these
genes as biomarkers and then performing cancer classification based on these
genes. Principal component analysis (PCA) has been used for the analysis of
gene expression data [78]. PCA enables researchers to reduce the dimension
and thus complexity of the data and explain the variation in the data based on first
4

few principal components. PCA is especially useful for visualization and clustering
of the samples based on their gene expression data [78]. In many of the
approaches, the variables are assumed fixed, but in many cases where the
predictor variables are random, such as gene expression data, assumptions can
be made that result in the same formulation as in fixed case [74]. One such
assumptions is a joint multivariate normal distribution for response and predictors,
other is an analysis of response conditioned upon the random predictors. For the
remaining discussion we will assume an appropriate assumption has been made.
Binary and Multi-category Classification Problems
DNA microarray technology shifted the scale of genomics research by
providing capabilities to study several thousands of genes at the same time in a
single experiment. DNA microarray measures the relative amount of mRNA.
Transcriptional changes reflect the status of disease including cancers and thus
gene expression profiles can be used in classification of different types of
cancer [69]. Binary classification problems deal with situations where phenotypes
have two possible categories. For instance, in cancer studies, gene expression
profiles can be used for classifying the samples into normal and tumor tissues.
When the phenotype under study has more than two categories, the multinomial
classification problem exists. Some classification algorithms naturally permit the
use of more than two classes while others are binary algorithms.
In several applications, the multi-class classification is reduced to several
binary classification problems. One strategy is training a single classifier per class
by considering samples of that class as positive and other samples as negative
5

samples [10]. Another approach creates

k
2



binary classifiers for a k-way multi

class problem. For each binary classifier, two sample types are used to train the
model to predict each of the two. At testing, all the classifiers are applied to each
sample and the class that has the most number of asignments is predicted by the
combined classifier [10]. Several methods have been developed that permit the
use of more than two categories of outcome such as logistic regression, and
Random Forests. In most of these methods, the probability of belonging to each
category of outcomes is predicted for each sample.
Cancer Classification Challenges and Shortcoming of Current Methods
Even though the DNA microarrays have made simultaneous monitoring of
thousands of gene expressions possible, sample sizes remain small, most of
them have less than 100 samples. On the other hand, the number of
genes-attribute space- is enormous. Each observation has thousands of genes
associated with it. Assume we mapped the samples in the attribute space, then
the samples will be very sparse in the high dimensional space. Most classification
algorithms are not powerful enough to deal with datasets with this kind of
characteristics. Thus, applying standard classification methods to such data will
result in several problems. High dimensionality and small sample size may give
rise to overfitting. Additionally, having so many genes results in expensive
computation time. Therefore developing an effective classification algorithm
based on gene expression data is not an easy task [103].
Another challenge arises from the presence of noise in the gene expression
data. The noise can be categorized into technical and biological noise [8]. The
6

noises introduced at various stages of data preparation is called technical noise.
The noise introduced by genes that are not relevant to the cancer classes is
called biological noise-most of the genes are not related to the cancer under
study. The presence of noise coupled with small sample size makes accurate
classification of tumor types very difficult [8]. The majority of genes in gene
expression data analysis are not related to the phenotype under study, dealing
with these huge number of irrelevant genes, which comprise a disproportionate
number of attributes in gene expression dataset, provides another challenge. In
most gene expression studies, the number of relevant genes comprise a small
portion of the total number of genes. Additionally, the presence of irrelevant genes
reduces the discriminating power of those relevant genes. Extracting these genes
from the pool of several thousands of genes is a big challenge.
The fourth challenge arises from the fact that classification accuracy is not the
only goal in cancer classification. Biological relevancy is another appealing
criterion to most biologists. Biological information revealed during the process can
help in further gene function discovery [103]. Therefore, classifiers that not only
produce high classification accuracy but provide insight into biology are desirable.
In order to highlight those variables that are most relevant to certain phenomena,
it is necessary to develop an approach to weed out unimportant variables.
To tackle this problem, several approaches based on the idea of single variable
analysis at a time have been proposed including: the t-test [21], a regression
modeling approach [87], mixture model approach [66] and non-parametric
methods [91]. The shortcoming of all these methods is that they are all univariate
7

variable selection methods. However, most complex phenomena are polygenic; a
single variable analysis can only detect a very small portion of variation and, also,
may not be powerful for identifying weaker associations [7]. In addition, it is very
common for different variables to interact with each other to form a complex
network of interactions, which cannot be characterized from individual analyses.
Thus, the need for new methods which are able to analyze large number of
variables becomes more obvious. Set based approaches to finding significant
variable have the following advantages to single variable analyses. First, by
inferring associations over sets of related variables, they can potentially decrease
uncertainty around variables and false positive. Second, the insights into the
functional links provided, facilitates interpretation of results. The last but not least,
they can potentially uncover a significant pattern distributed over multiple
variables while the changes in individual variables have a small effect providing a
much better framework to investigate architecture of complex diseases. In order
to address limitations that come with single variable analysis methods, lots of
research has focused on the development of various approaches for simultaneous
analysis of multiple variables [53, 94, 98].
In linear regression framework, least square method is used to obtain estimate
of parameters. The ordinary least square estimates obtained are not quite
satisfactory mainly due to poor accuracy of prediction resulting from high
variances of estimates and poor performance when the dataset at hand contains
large number of variables with small sample size [88]. Often, one would like to
establish a smaller subset which offers the strongest effect and discriminating
8

power. It is believed that prediction accuracy can be improved by setting the
parameters associated with unimportant variables to zero and thus obtaining
more accurate prediction for significant variables [88]. Traditionally, by using
forward selection, backward elimination, and stepwise selection a subset of
predictors in a regression framework is obtained. However, these approaches are
computationally expensive and unstable even when the number of predictors is
not large [7]. Furthermore, in this setting there are thousands of variables
compared to small sample size at hand which can result in over fitting and can fail
to identify important predictors. Thus, the data structure makes it impossible to
use traditional multivariate regression for analysis [48]. Researchers have used
logistic regression extensively when the response variable is binary and
multi-category. But for the data structure explained above, procedures
incorporated into the software packages to obtain maximum likelihood estimates
of parameters will become computationally intensive and sometimes intractable.
In addition, the maximization process may not converge to the maximum
likelihood estimates and predictors may have large estimated variances resulting
in poor prediction accuracy [70].
There has been a great effort to develop methods that are able to analyze lots
of variables simultaneously by inducing sparseness in the model while
highlighting the relevant variables. Least Absolute Shrinkage and Selection
Operator (LASSO) work by Tibshirani in 1996 drew much attention to the
area [88]. There exists a rich literature discussing methods to analyze the LASSO
and related approaches [45, 104, 107, 108]. After the work of [89] and [27],
9

Bayesian approach to the same problem gained interest. A Bayesian LASSO was
proposed by park and Casella (2008) and Hans (2009), [37, 67]. However, these
procedures may cause over-shrinking of large coefficients due to the relatively
light tails of the double exponential prior thus introducing major bias. Using a
normal-Jeffreys prior which has heavier tails than the double exponential
distribution, small coefficients may shrink to zero while minimally shrinking large
coefficients and thus obtaining better results. However use of this prior has no
meaning from an inferential aspect as it results in an improper posterior [5]. An
alternative class of hierarchical priors were proposed that uses Bayesian adaptive
Lasso with non-convex penalization [90]. However, it lacks simple analytic form.
Armagan et. al (2011) proposed the Generalized Double Pareto (GDP) prior
distribution [5] . The properties of this distribution that makes it appealing include:
having a spike at zero alongside student-t like tails, a simple analytic form and
yielding a proper posterior. In addition, it resembles the double exponential
density in the neighborhood of zero and has heavier tails compared to double
exponential, remedying unwanted bias resulting from over shrinkage of
parameters toward zero [5].
Classification Accuracy and Biological Relevance
Another challenging problem in analyzing gene expression data is the fact
that identification of a set of biologically relevant markers with high predictive
power remains difficult. Several machine learning algorithms have been used for
cancer classification with promising results. However, majority of machine
learning algorithms are geared toward obtaining the highest classification
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accuracy and do not take into account the biological relevance of the markers
obtained. Thus, in the majority of applications markers found do not convey
meaningful biological information and are merely good classifiers. Thus, a
machine learning schema that is able to bridge classification accuracy and
biological relevance will be of high merit to the community and can potentially
result in deeper understanding of mechanisms involved.
GCAT is a web-based tool that determines the functional coherence of gene
sets by performing latent semantic analysis of Medline abstracts [96]. In GCAT,
each gene –document was generated by concatenation of all titles and abstracts
of the Medline. After gene-document was collected, latent Semantic Analysis
(LSA) is used to calculate the gene-gene similarity matrix. LSA is a variant of the
vector space model that reduces the dimensions of the matrix by applying
Singular Value Decomposition (SVD) so that genes can be compared more
conceptually [39]. Thus, LSA allows extraction of both explicit and implicit gene
relationships from the literature. In a vector space Model, the semantic structure
of a document is represented as a vector in word space and the degree of
similarity between documents is calculated by the cosine of the angles between
document vectors [39, 96]. Given any set of genes, GCAT calculates the cosine
distribution of the gene set compared with that of a random gene set. More
specifically, Fisher’s Exact test is used to determine if the number of gene
relationships above the cosine value 0.6 is significantly different from that which is
expected by chance. The p-value obtained from this procedure is called Literature
derived p-value (Lpv) [96]. Small Lpv values indicate that the input gene list are
11

functionally cohesive as opposed to random set of genes. In what follows we use
GCAT to assess the biological relevance of set of markers obtained from our
model.
Dissertation Outline
In this thesis we integrated double exponential prior and Generalized
Double Pareto prior into the Bayesian Generalized Linear Models framework to
induce sparseness in situations with the number of parameters to be predicted far
exceeding the number of samples. In Chapter 2, we develop a hierarchical
Bayesian Generalized Linear Model for binary response situations using
Generalized Double Pareto prior on model parameters. In chapter 3, we develop a
sparse Bayesian multinomial model that can handle multi-category response
variables that are ordinal in nature. The model is applied and tested on a prostate
cancer progression data set [90]. In chapter 4, we extend the model developed in
chapter 2 in order to handle situations with ordinal response variables in
Generalized Linear Models framework. This model was tested on a prostate
cancer stages data set. Resampling techniques were used in order to remove the
bias caused by the choice of training and test samples.
We performed 50 resamplings on the training and test samples and the
average accuracy of the model across 50 runs was reported. We investigated the
effect of literature aided initial input variable list on model performance in chapter
5. In chapter 6, we developed a literature aided sparse Bayesian generalized
linear model that incorporates literature information to guide choice of
hyper-parameters and amount of shrinkage imposed in the model thus bridging
12

predictive power and biological relevance of markers obtained. Chapter 7
includes discussion on future work.
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Chapter 2
A Bayesian Approach for Inducing Sparsity in Generalized Linear Models
Using Generalized Double Pareto Prior
Abstract
Identification of marker genes for classification of samples using microarray or
RNAseq expression data remains challenging. In these settings, the data sets
often contain a large number of variables (genes) and a relatively small number of
samples which may render the variable selection process unstable. In addition,
single variable analysis methods are too simple to give a comprehensive picture
of the molecular mechanisms underlying complex phenotypes. Therefore,
methods are needed to shrink the number of variables (induce sparsity) to avoid
over-fitting, while accommodating simultaneous analysis of a large number of
genes despite small sample sizes. The Generalized Double Pareto (GDP) prior is
used to induce sparsity in a Bayesian generalized linear model setting. The GDP
distribution has a spike at zero like the double exponential density, but has a
Student t-like tail which helps remedy over-shrinkage of signals toward zero. In
this study, a fully Bayesian hierarchical model was developed in order to facilitate
Gibbs sampling. The GDP model was evaluated using three published datasets
on leukemia and breast cancer. For each experiment, we randomly divided the
samples into training and test groups. For each data set, using the top 10 genes,
the GDP model achieved higher classification sensitivity (0.91-1.0) than the
double exponential model (0.86-1.0). Interestingly, we found that the GDP model
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identified marker genes with high literature derived functional cohesion. The top
100 genes identified by the GDP model had a literature p-value ranging from
2.06E-7 to 4.49E-24 for the three data sets, compared to the double exponential
model (1.1E-3 to 3.13E-6). We conclude that the Bayesian sparse model with
GDP prior results in better classification and more functionally relevant marker
genes.
Introduction
High throughput expression studies are commonly used to identify genes that
contribute mechanistically to a phenotype or provide biomarkers for classification
of samples related to a given phenotype. A major challenge in analysis of gene
expression is that relatively few samples are analyzed with respect to many
thousands of gene expression variables. To address this problem, several
approaches based on the idea of single variable analysis have been
proposed [22, 66, 86, 91]. The shortcoming of all these methods is that they are
univariate gene selection methods. However, most complex traits are polygenic
so that a single variable analysis can only detect a very small portion of covariants
and may not be powerful enough to identify weaker effects [7]. In order to address
limitations that come with single variable analysis methods, recent efforts have
focused on the development of various approaches for simultaneous analysis of
multiple variables [53, 94, 98].
Traditionally, by using forward selection, backward elimination, and stepwise
selection a subset of predictors in a regression framework is obtained. However,
these approaches are computationally expensive and unstable even when the
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number of predictors is small, [7, 48]. Researchers have used logistic regression
extensively when the response variable is binary. But for the data structure
explained above, procedures used to obtain maximum likelihood estimates of
parameters will become computationally intensive and sometimes intractable. In
addition, the maximization process may not converge to the maximum likelihood
estimates and predictors may have large estimated variances which results in
poor prediction accuracy [70].
It was previously proposed that prediction accuracy can be improved by setting
the unimportant parameters associated with variables to zero and thus obtaining
more accurate prediction for significant variables, [88]. There has been a great
effort to develop methods that are able to analyze many variables simultaneously
by inducing sparseness in the model while highlighting the relevant variables.
Least Absolute Shrinkage and Selection Operator (LASSO) work by Tibshirani in
1996 drew much attention to the area. There exists a rich literature discussing
methods to analyze the LASSO and related approaches [45, 104, 107, 108]. After
the work of [27, 89] Bayesian approach to the same problem gained interest. A
Bayesian LASSO was proposed recently by [67] and [37]. However, these
procedures may cause over-shrinking of large coefficients due to the relatively
light tails of the double exponential prior, and thus may introduce major bias.
Using normal-Jeffreys prior which has heavier tails than double exponential
distribution, we would be able to shrink small coefficients to zero while minimally
shrinking large coefficients and thus obtaining better results. However, it has no
meaning from an inferential aspect as it leads to an improper posterior, [5].
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An alternative class of hierarchical priors proposed in [33] that uses Bayesian
adaptive Lasso with non-convex penalization. However, it lacks simple analytic
form. In [5], authors proposed the Generalized Double Pareto (GDP) prior
distribution with application to continuous outcomes. The properties of this
distribution that makes it appealing include: having a spike at zero alongside
student-t like tails, simple analytic form and yielding proper posterior. In addition,
it resembles double exponential density in the neighborhood of zero and has
heavier tails compared to double exponential remedying unwanted bias resulting
from over shrinkage of parameters toward zero [5].
In this article, we integrated a GDP prior into the Bayesian generalized linear
models framework to induce sparseness in situations where the number of
parameters to be predicted far exceeds the number of samples. The model
developed can be used to analyze binary phenotypes. In step one, we derive the
fully conditional distributions for all parameters in a multi-level hierarchical model
in order to perform the fully Bayesian treatment of the problem. In the second
step, the Markov Chain Monte Carlo (MCMC) method based on Gibbs sampling
algorithm developed in step one is used to estimate all the parameters [30, 31].
The model shows a great flexibility to fit many variables at the same time. We
apply our method to a leukemia dataset, [32], and two breast cancer tumor data
sets [18] and [93]. The goal of the study is three-fold: Identification of a small
number of genes having the greatest discriminating power in order to allow
researchers to quickly focus on the most promising candidates for diagnostics and
therapeutics, using the developed model to obtain the probability of each sample
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belonging to one of the categories of phenotype, and obtaining high classification
accuracy. In addition, we expect to not only achieve the above goals but also
identify more biologically relevant genes to the phenotype under study.
Methods
In many different fields of science such as gene expression analysis
continuous outcome variables are not very common and most often we are faced
with dichotomous or multi-level response variables. In these situations, the simple
linear regression model which is designed for analyzing models with continuous
outcome variables is not appropriate. Generalized linear models (GLM) provide a
way to handle these situations. Consider a situation with binary response. Let
y1 , y2 , ..., yn represent the observed response variables in which ‘n’ is the number
of observations (samples). Here yi can take on 0 or 1 if for example the sample is
normal or cancer respectively. In the case of gene expression analysis, gene
expression levels are measured for each sample and we let wij represent the
expression level of gene j in the ith sample. In the context of GLM, nonlinear link
functions are used to associate the nonlinear, non-continuous response variable
to the linear predictor wi T θ in which θ is a 1*p vector of θ=[θ1 , .., θp ]T associated
with covariate vector wi =[wi1 , .., wip ]T . Let H represent this link function. The GLM
model can be represented as [1, 62]:
H(E(yi )) = H(P (yi = 1)) = wi T θ

(2.1)

In this formula, wi is the vector of covariates for individual i. We used logistic
link function which corresponds to logistic regression [62].
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H(P (yi = 1)) = H(Pi ) = ln

Pi
1 − Pi


;

where Pi = P (yi = 1)

(2.2)

In order to be able to find the posterior distributions of parameters, we need to
integrate the likelihood function multiplied by joint prior distributions of all
parameters. However, this approach will result in an intractable integration. As
explained in [1], in order to be able to set up the Gibbs sampler, we introduce ’n’
independent latent variables l1 , l2 , ..., ln defined as li = wiT θ + ei . We assume
logistic distribuion on error temrs, F (ei ) =

1
,
1+e−ei

to obtain logistic regression. In

order to be able to set up the Gibbs sampler, we approximate the logistic
distribution on the latent variables with t-distribution defined as li ∼ tv (wi T θ). The
reason for choosing t-distribution is that logistic distribution has heavy tails and
normal distribution does not provide a good approximation. Hence, we used
student-t distribution with v degrees of freedom on latent variables to provide a
better approximation for distribution on latent variables. We treat the degrees of
freedom as unknown and estimate it alongside other parameters. It should be
noted that this distribution is a non-central t-distribution with v degrees of freedom
and non-centrality parameter wi T θ. The following relationship is established
between response and corresponding latent variable.




1 if li ≥ 0
yi =



0 Otherwise

This way the response and latent variables are linked in binary outcome
situations. This approach connects the logistic regression for yi to a linear
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regression model for the latent variable li , [1]. The probability of each sample
belonging to the category 1 can be calculated as follows.
p(yi = 1) = p(li ≥ 0) = p(ei ≥ −wiT θ) = p(ei < wiT θ) =

1
T
1 + e−wI θ

Bayesian Hierarchical Model and Prior Distributions
In order to sample li from tv (wi T θ), we use the following hierarchical model
which is equivalent to sampling from the corresponding t-distribution [34]. This
two-level hierarchical form is easier to work with both analytically and
computationally compared to the original form of the t distribution [34]. This two
level hierarchical distribution enables us to obtain closed forms for fully conditional
posterior distributions of parameters.
li |Λi , θ ∼ N (wi T θ,

v v
1
); Λi ∼ Gamma( , )
Λi
2 2

Here gamma distribution is defined as π(x|α, β) =

β α α−1 −βx
x e .
Γ(α)

(2.3)

We put

independent generalized double Pareto priors on all θ s. This prior is defined as
follows, [5].
f (θ|ζ, ρ) =

|θ|
1
∗ (1 + )−(1+ρ) ; ρ, ζ > 0
2ζ
ρζ

(2.4)

Letting θj ∼ GDP (ζ = ρδ , ρ) independently, the joint distribution of θs is defined as
follows [5].

p
Y
1
|θj | −(1+ρ)
π(θ) =
[ δ ∗ (1 +
)
]
δ
2
j=1 ρ

(2.5)

GDP prior can be represented as a scale mixture of normal distributions leading
to computational simplifications that makes Gibbs sampling feasible [5]. The
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GDP ( ρδ , ρ) prior is equivalent to the following hierarchical representation [5].
θj |τj ∼ N (0, τj ); τj ∼ Exp(

λj 2
); λj ∼ Gamma(ρ, δ)
2

(2.6)

The hyper parameters ρ and δ control the shape of the GDP distribution and
thus the amount of shrinkage induced [5]. As δ increases the distribution
becomes flatter and variance increases. As ρ increases the tails of distribution
becomes lighter, variance becomes smaller, and the distribution becomes more
peaked [5]. Thus, large values of ρ may cause unwanted bias for large signals
and stronger shrinkage for noise-like signals while larger values of δ flattens the
distribution and we may lose the ability to shrink noise-like signals [5]. In the
absence of information on hyper parameters one can either set them to default
values (ρ = δ = 1) or choose a hyper prior distribution and let data speak about
the values of these hyper parameters. We adopt the following prior distributions
for these parameters.

π(ρ) =

1
c
; c > 0 ⇒ median(ρ) =
2
(1 + cρ)
c

(2.7)

π(δ) =

c0
1
;
c
>
0
⇒
median(δ)
=
(1 + c0 δ)2
c0

(2.8)

The priors on ρ and δ correspond to generalized Pareto priors with location
parameter 0, shape parameter 1, and scale parameters c−1 and c0 −1 respectively.
As mentioned in the above formula, c and c0 determine the location of the median
of the distribution of parameters ρ and δ . For sampling purposes, we do the
following transformations that leads to uniform prior distribution for the new
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parameters (the proof is given in appendix 1) [5].

u1 =

1
;
1 + cρ

u2 =

1
1 + c0 δ

(2.9)

Defining the parameters as above, the hierarchical representation of the model



is as follows. li |Λi , θ ∼ N wi T θ, Λ1i , Λi ∼ Gamma v2 , v2 , θj ∼ N (0, τj ),
 2
λ
τj ∼ Exp 2j , λj ∼ Gamma (ρ, δ), and we use non-informative uniform prior on
v. Using the above mixture representation for the parameters and defining the
prior distributions, we obtain following fully conditional posteriors that lead to a
straightforward gibbs sampling algorithm. The derivation of fully conditional
posterior distributions is presented in appendix1.

li |− ∼ T N

1
wi θ,
Λi
T


(2.10)

In equation 2.10, ‘TN’ stands for truncated normal distribution, li is sampled from
truncated normal distribution with parameters defined above. Point of truncation is
zero and in each iteration of the Gibbs sampling, each li is sampled from above
the truncation point if corresponding yi is 1 and it will be sampled from the below
the truncation point otherwise.
θ|− ∼ M V N



T

W ΛW + T


∗ −1

T



T

W ΛL, W ΛW + T


∗ −1



(2.11)

The normal distribution defined above is a multivariate normal distribution with
mean vector and variance covariance matrix as specified. Where,
∗
Tp∗p
= diag(τ1 −1 , ..., τp −1 ), Λn∗n = diag(Λ1 , ..., Λn ), and W is the n*p design matrix
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in which wij represents expression level of gene j in the ith sample.
s
!
2
λ
j
, λj 2
τj −1 |− ∼ Inv − Ggaussian
θj 2

(2.12)

In equation 2.12, Inv-Gaussian denotes inverse Gaussian distribution with
q 2
λ
location θjj2 and scale λj 2 . Each λj and Λj are sampled according to equation
2.13 and 2.14 respectively.
λj |− ∼ Gamma (ρ + 1, |θj | + δ) ; j = 1, .., p


Λr |− ∼ Gamma



v+1 1
T
2
, (lr − wr θ) + v ; r = 1, .., n
2 2

(2.13)

(2.14)

The fully conditional distributions for v, u1 , and u2 are represented in equations
2.15 to 2.17 [5].
"
v|− ∝

n
Y

Λi

v
−1
2

i=1


u1 |− ∝


u2 |− ∝

exp

−vΛi
2

# "Y
n
∗

v
2

v
2

#

Γ( v2 )
n=1

(2.15)

p Y
−( 1−u
1 +1)
p 
cu1
|θj |
∗
1+
δ
j=1

(2.16)

p Y
−(1+ρ)
p 
c0 u2
∗
1+
|θj |
1
−
u
2
j=1

(2.17)

1 − u1
cu1

c0 u 2
1 − u2



As we can see, the fully conditional distributions of v, u1 , and u2 do not have
closed form and thus we adopt the following embedded giddy gibbs sampling to
sample from v, ρ, and δ [5, 75]. On a grid of k values (v1 , v2 , ..., vk ) representing
values of degrees of freedom considered, we perform the following
procedure [5, 75].
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• Calculate the weights as ri = π(vi |−) according to formula 2.15.
• Normalize the weights ri N =

r
Pk i

i=1 ri


• Sample one value from (v1 , v2 , ..., vk ) with probabilities r1 N , r2 N , ..., rk N .
On a grid of values in interval (0, 1) we use the same procedure to sample one
value from u1 and u2 to use in the current iteration of Gibbs sampling. The only
difference is that at the end of the procedure we transform u1 and u2 back to ρ and
h
i
h
i
δ using ρ = 1c u11 − 1 and δ = c10 u12 − 1 respectively. The concise description of
the Gibbs sampling algorithm explained above is represented in figure 1.
Datasets
The model was evaluated using one leukemia dataset [32] and two different
breast cancer data sets [18] and [93]. The Golub leukemia data set included bone
marrow or peripheral blood samples from 72 patients with either acute
lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). The gene
expression levels for 7129 human genes were measured for this cohort. For our
study, this dataset was randomly split into a training group of 38 samples
containing 27 ALL and 11 AML samples and a test group of 34 samples
containing 20 ALL and 14 AML samples [32]. The Chin breast cancer data set
contains gene expression profiles in 118 primary breast tumors (28 basal-like and
90 non-basal like) from a cohort of patients treated according to the standard of
care between 1989 and 1997 [18]. The dataset was randomly divided into two
training and test groups such that each group contains equal number of basal-like
and non-basal samples. The Wang breast cancer data set contains gene
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expression profiles in 249 breast tumors (43 basal-like samples and 206
non-basal) from patients with lymph-node negative breast cancer who were
treated during 1980–1995, but who did not receive systemic neo-adjuvant or
adjuvant therapy [93]. The dataset was randomly divided into two training and test

Figure 1: Gibbs sampling algorithm for model with Generalized Double Pareto
prior and binary response.
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groups such that each group contained equal sample number of basal-like and
non-basal samples.
Results
For each data set, we used top five hundred differentially expressed genes as
input to our model. For each of the train groups, the Gibbs sampler is run for
60,000 iterations and we discard the first 20,000 samples as burn in. In order to
sample hyper parameters ρ and δ, we set c and c0 to 1 to achieve the standard
behavior of GDP prior [5]. Genes were selected based on posterior mean of θ
associated with each gene. Figure 2 represents posterior mean of θ s for the 500
genes input to the model for the Golub data set. While some noise like signals are
reduced toward zero, other signals stand out which turn out to be biologically
more relevant to AML and ALL. Additionally, we obtained another sparse
Bayesian Generalized linear model by imposing double exponential prior on θs
(SBDE), [37, 56, 57, 67]. We used our model for class prediction of AML and ALL
samples on the leukemia data set and basal-like and non-basal tumor samples in
the breast cancer data sets. For example, the probability of a new sample being
ALL was calculated as follows.

P (ynew = 1) =

1


1 + exp −wi T θ̂

(2.18)

In this formula, θ̂ is the posterior mean of θ s obtained for each train group and
wi is the vector of gene expression values associated with the corresponding θ̂ s
used for prediction. Using only the first top ten genes-obtained from training the
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Figure 2: Posterior mean of θ asociated with each gene.
model on train groups ,we analyzed percent correct classification (accuracy),
sensitivity, and specificity as measures of evaluation of the model. Sensitivity and
specificity are statistical measures that evaluate performance of binary
classifiers [4]. Sensitivity measures the proportion of actual positives (e.g.
basal-like) that are identified by the model to be positive (e.g. basal-like) and
specificity measures the proportion of negatives (e.g. non-basal) that are correctly
classified as negative (e.g. non –basal). As a measure of the robustness of the
model, we switched train and test groups for each data set and run the model
again and obtained the classification results on the new test groups. Table 1 and
2 show the classification results on the test groups for each data set obtained
using our model compared to SBDE. Also, the sensitivity and specificity of the
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Table 1: Classification accuracy, sensitivity, and specificity for test groups.
DataSet
Golub
Golub
Gray
Gray
Wang
Wang

Model
GDP
SBDE
GDP
SBDE
GDP
SBDE

Accuracy
0.941
0.912
0.949
0.966
0.976
0.952

Sensitivity
1
0.95
0.84
0.86
0.91
0.86

Specificity
0.86
0.86
1
1
0.99
0.97

Table 2: Classification Accuracy, Sensitivity, and specificity for test group. Train
and test groups switched
DataSet
Golub
Golub
Gray
Gray
Wang
Wang

Model
GDP
SBDE
GDP
SBDE
GDP
SBDE

Accuracy
0.921
0.895
0.949
0.932
0.92
0.911

Sensitivity
0.89
0.85
0.79
0.71
0.92
0.71

Specificity
0.91
0.91
1
1
0.93
0.95

classification when train and test groups were switched are show in Table 2 for
test groups.
Latent Semantic Analysis(LSA) is a technique in natural language processing
used for analyzing the relationships between a set of documents and the terms
they contain by producing a set of concepts related to documents and terms [39].
Medline is the premier bibliographic database for biomedicine supported by
national library of medicine. GCAT is a web-based tool that determines the
functional coherence of gene sets by performing latent semantic analysis of
Medline abstracts [96]. In GCAT, each gene –document was generated by
concatenation of all titles and abstracts of the Medline. After gene-document was
collected, latent Semantic Analysis (LSA) is used to calculate the gene-gene
similarity matrix. LSA is a variant of the vector space model that reduces the
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Table 3: GCAT top 100 genes’ p-values for the GDP model compared to model
with double exponential prior (SBDE).
DataSet
Golub
Gray
Wang

T-test
GDP
0.19
2.1E-7
3.1E-5
2.9E-8
7.44E-40 4.49E-24

SBDE
0.0015
0.0011
3.13E-6

dimensions of the matrix by applying Singular Value Decomposition (SVD) so that
genes can be compared more conceptually [39]. Thus, LSA allows extraction of
both explicit and implicit gene relationships from the literature. In a vector space
Model, the semantic structure of a document is represented as a vector in word
space and the degree of similarity between documents is calculated by the cosine
of the angles between document vectors [39, 96]. Given any set of genes, GCAT
calculates the cosine distribution of the gene set compared with that of a random
gene set. More specifically, Fisher’s Exact test is used to determine if the number
of gene relationships above the cosine value 0.6 is significantly different from that
which is expected by chance. The p-value obtained from this procedure is called
Literature derived p-value (Lpv) [96]. Small Lpv values indicate that the input gene
list are functionally cohesive as opposed to random set of genes.
We utilized GCAT to obtain the literature p-value for the top 100 genes
obtained from t-test, SBDE, and GDP model. The results of the analysis is shown
in Table 3. As we can see the p-values obtained under our model is highly more
significant compared to SBDE which indicates that our model results in more
biologically relevant genes compared to SBDE and t-test.
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Discussion
Microarray gene expression technology continues to be used to obtain more
understanding of mechanisms of human diseases, develop classifiers for
prediction of poor versus good outcomes, and to detect relevant signals amidst a
large body of noises [25, 65]. These information can be used for tailoring the
treatments towards individuals [13, 72]. Gene expression studies usually measure
several thousands of genes across the entire genome for few number of samples.
Statistical modeling becomes challenging as the familiar “large p small n
situations” arises. Identification of biologically relevant markers as well as ability
to classify samples are of high interest among the community. Previous studies
have shown that the correct selection of subsets of genes from microarray data is
key for accurate classification of disease phenotypes, [17, 23].
In order to highlight those covariates that are most relevant to certain
phenotype, it is necessary to develop an approach to weed out unimportant
covariates [102]. Models that induce sparsity in terms of number of covariates in
the model are of interest in order to obtain reliable and accurate predictions by
learning classifiers [52]. It has been shown that majority of informative markers
may not be highly differentially expressed and thus models that use very
light-tailed priors are prone to the danger of losing biologically valuable
information contained in these markers [47].
The key contribution of this work is to utilize a Generalized Double Pareto prior
and develop a sparse Bayesian hierarchical Generalized linear model that can

30

accommodate binary phenotypes, obtain high classification accuracy, and identify
biologically relevant genes at the same time. In our model, while shrinking small
effects toward zero and producing sparse solutions, the over shrinkage problem
caused by using light-tailed priors would be remedied by the heavier tails obtained
via mixing over the hyper parameters using GDP prior [5]. We applied the model
to the leukemia data set [32], and two breast cancer data sets [18] and [93]. We
used the model to do prediction of sample type on the test datasets. The
Bayesian set up enables us to assign the samples to one of the categories in a
coherent way. Classification accuracy, sensitivity, and specificity were used as
measures of model performance. As shown in table 1 and 2, the model developed
obtains high classification accuracy, sensitivity and, specificity in all 3 data sets
and outperforms the SBDE model in all cases except 1.
In order to test robustness of the model, we switched training and test data set
and trained the model on the new train dataset and performed classification on the
new training and test data sets. In this case the model results in better classifying
accuracy in all three data sets which is in accordance with the results obtained in
the first analysis. GCAT literature p-value of the top 100 genes obtained from the
model represents the biological relevance of markers obtained [96]. Our model
results in more significant literature based p-values which indicates that more
biologically relevant genes are obtained using our model compared to SBDE. In
conclusion, using the GDP prior in a Bayesian generalized linear models frame
work we were able to achieve high classification accuracy and obtain biologically
relevant marker genes to the outcomes in each experiment.
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There exists a possibility of utilizing Metropolis–Hastings algorithm instead of
Griddy Gibbs sampling algorithm employed to sample hyper-parameters v, u1 , u2 .
Metropolis Hastings is a Markov chain Monte Carlo (MCMC) method for obtaining
a sequence of random samples from a probability distribution for which direct
sampling is difficult [31]. The Metropolis–Hastings algorithm can draw samples
from any probability distribution P (x), provided you can compute the value of a
function f (x) which is close to the density of P . On the other hand, most simple
rejection sampling methods suffer from the dimensionality, where the probability
of rejection increases exponentially as a function of the number of
dimensions [31]. Metropolis Hastings algorithm is only useful when you can find a
suitable “jumping” density which is “similar” (close) to its target density to avoid
excessively slow mixing [31]. This is a difficult task, especially for
high-dimensional space. In addition, the metropolis algorithm within each iteration
on the last part of the MCMC procedure would dramatically increase the running
time of the MCMC process.
In future, we plan to incorporate literature information into the prior
distributions in order to design literature informed priors that would potentially
enable us to obtain machine learning models with high classification accuracy
which provide very enriched set of markers with high biological relevance to the
phenotype under study. This potential development which could bridge the gap
between classification accuracy and biological relevance will be of high merit to
the community and can potentially result in deeper understanding of mechanisms
involved. The model developed here should be extendable to datasets with
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multi-level response variables. In chapter 3 and chapter 4, we explore the
development of sparse bayesian generalized linear models to address
multi-category response situations.
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Chapter 3
Application of Sparse Bayesian Generalized Linear Model to Gene Expression Data for Classification of Prostate Cancer Subtypes
Abstract
A major limitation of expression profiling is caused by the large number of
variables assessed compared to relatively small sample sizes. In this study, we
developed a multinomial Probit Bayesian model which utilizes the double
exponential prior to induce shrinkage and reduce the number of variables in the
model. A hierarchical Sparse Bayesian Generalized Linear Model (SBGLM) was
developed in order to facilitate Gibbs sampling which takes into account the
progressive nature of the response variable. The method was evaluated using a
published dataset (GSE6099) which contained 99 prostate cancer cell types in
four different progressive stages [90]. Initially, 398 genes were selected using
ordinal logistic regression with a cutoff value of 0.05 after Benjamini and
Hochberg FDR correction. The dataset was randomly divided into training (N=50)
and test (N=49) groups such that each group contained equal number of each
cancer subtype. In order to obtain more robust results we performed 50
re-samplings of the training and test groups. Using the top ten genes obtained
from SBGLM, we were able to achieve an average classification accuracy of 85%
and 80% in training and test groups, respectively. To functionally evaluate the
model performance, we used a literature mining approach called Geneset
Cohesion Analysis Tool [96]. Examination of the top 100 genes produced an
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average functional cohesion p-value of 0.007 compared to 0.047 and 0.131
produced by classical multi-category logistic regression and Random Forest
approaches, respectively. In addition, 96% of the SBGLM runs resulted in a GCAT
literature cohesion p-value smaller than 0.047. Taken together, these results
suggest that sparse Bayesian Multinomial Probit model applied to cancer
progression data allows for better subclass prediction and produces more
functionally relevant gene sets.
Introduction
As data collection technologies evolve, the number of variables which can be
measured in experiments increase. For example, modern microarray experiments
can measure the expression levels of several thousand genes simultaneously.
Since the number of samples is typically much smaller than the number of
variables, it is challenging to identify important genes among the large amount of
data points [15]. Many univariate analysis approaches have been applied to select
important genes from microarray experiments such as t-test [21], regression
modeling [87], mixture model [66] and non-parametric methods [24, 91]. However,
since most complex traits are polygenic, a single variable analysis can only detect
a very small portion of the relevant variation and may not be powerful enough to
identify weaker interactions between the variables [7].
In order to address limitations of single variable analysis methods, several
approaches have been developed for simultaneous analysis of multiple
variables [53, 94, 98]. In linear regression framework, the least square method is
used to obtain estimate of parameters. The ordinary least square estimates
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obtained are not quite satisfactory mainly due to poor accuracy of prediction
resulting from high variances of estimates, the large number of variables with
respect to small sample size, and the error in variables [88]. It is preferred to
select a smaller subset of variables, sometimes referred to as feature selection,
which offer the strongest effect and discriminating power. A standard method
used to improve the parameter estimation, prediction, and classification is subset
selection and its variants such as backward elimination, forward and stepwise
selections. These methods are all discrete processes and can be highly
inconsistent, meaning that a small change in the data can result in very different
models [45, 48, 70, 88, 104, 107]. In addition, these approaches are
computationally expensive and unstable when sample sizes are much smaller
than the number of variables [49, 88]. Moreover in this setting, over-fitting is a
major concern and may result in failure to identify important predictors. Thus, the
data structure of typical microarray experiments makes it difficult to use traditional
multivariate regression analysis [7]. Given the aforementioned drawbacks, several
groups have developed methods to simultaneously analyze a large number of
variables [26, 49, 64, 101, 107]. It has been proposed that prediction accuracy can
be improved by setting the parameters associated with unimportant variables to
zero and thus obtaining more accurate prediction for the significant variables [88].
Various methods such as K-nearest neighbor classifiers [24], linear
discriminant analysis [99], and classification trees [24] have been used for
multi-class cancer classification and discovery [14, 20, 73]. However in all these
methods, gene selection and classification are treated as two distinct steps that
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can limit their performance. One alternative to deal with these situations is using
Generalized Linear Models (GLM) [37, 58, 60, 62]. Researchers have used GLM
methodology extensively when the response variable is not continuous. But for
typical microarray experiments, procedures to obtain maximum likelihood
estimates of parameters will become computationally intensive and sometimes
intractable. In addition the maximization process may not converge to the
maximum likelihood estimates and predictors may have large estimated variances
which results in poor prediction accuracy [70]. In order to avoid over-fitting and
improve model accuracy, models which impose sparsity in terms of variables
(genes) are desirable [88]. Least Absolute Shrinkage and Selection Operator
(LASSO) is a well-known method for inducing sparseness in the model while
highlighting the relevant variables [45, 88, 95, 107]. A Bayesian LASSO method
was proposed by [37, 67] in which double exponential prior is used on parameters
in order to impose sparsity in the model. In this article, we integrate double
exponential prior distribution into the Bayesian generalized linear model
framework to induce sparseness in situations where the number of parameters to
be predicted exceeds the number of samples. The model developed can be used
to analyze multi-category phenotypes such as progressive stages of cancer. In
step one, we derive the fully conditional distributions for all parameters in a
multi-level hierarchical model in order to perform the fully Bayesian treatment of
the problem. In the second step, the Markov Chain Monte Carlo (MCMC)
method [30, 31] based on Gibbs sampling algorithm is used to estimate all the
parameters. This model takes into account the ordinal nature of the response
37

variable. We applied and evaluated our model to a publicly available prostate
cancer progression dataset [90]. The goals of the study are to test if a hierarchical
Sparse Bayesian Generalized Linear Model (SBGLM) can: 1) Identify a smaller
number of genes with high discriminating power; 2) Obtain high classification
accuracy; 3) Identify more biologically relevant genes related to the phenotype
under study.
Methods
In many biomedical research applications, dichotomous or multi-level outcome
variables are desired. In these situations, the simple linear regression model
which is designed for continuous outcome variables is not appropriate due to
heteroscedasticity and non-normal errors. Furthermore, there is no guarantee
that the model will predict legitimate responses (e.g. 1, 2, 3, and 4 in polytomous
response variable with 4 levels). Generalized linear models (GLM) provide a way
to address these situations [58, 60, 62]. Let [yi , wi1 , ..., wip ]ni=1 represent n
observations in which the response variables yi can take values 1, 2, 3, .., k
where k is the number of categories of the ordinal response variable. In addition,
let (wi1 , .., wip ) represent the value of variable 1 to variable p in observation 0 i0 . In
the case of gene expression analysis, gene expression levels are measured for
each sample and wij represents expression level of gene j in ith sample. We
implemented GLM for ordinal response in Bayesian framework by utilizing link
functions and careful introduction of latent variables [1]. In Bayesian framework,
the joint distribution of all parameters is proportional to the likelihood multiplied by
the joint prior distributions on the parameters. More specifically, in Bayesian
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Multinomial Probit Model, the likelihood function is defined as in formula (3.1) in
which πij is the probability that sample i is from j th category where j ranges from 1
to k and k is the number of ordinal categories of response variable [1]. In formula
3.1, I(yi = j) is an indicator function having value one if the yi is in category j and
zero otherwise. It should be noted that each observation contributes one value in
the inner product to the equation (3.1) since the indicator function returns value of
zero if j is not equal to the category of outcome for the sample.
L(π|y) =

" k
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Y
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i=1
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πij
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In order to be able to find the posterior distributions of parameters, we must
integrate the likelihood function multiplied by joint prior distributions of all
parameters. However, this approach will lead to an intractable integration. As
explained in [1], in order to be able to set up the Gibbs sampler and incorporate
regression parameters into the model, we introduce ‘n’ independent latent
variables l1 , l2 , ..., ln defined as li = wiT θ + ei with ei ∼ N (0, 1) [1]. In this formula,
wiT is the vector of gene expressions for individual i and θ = (θ1 , .., θp ) are
parameters associated with variable 1 to variable p. The following relationship is
established between response variable and its corresponding latent variable [1].
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γk ≤ li < γk+1 = ∞

In order to insure that the thresholds are identifiable, following the guidelines
of [1], we fix γ2 at zero and γ1 and γk+1 are defined according to equation above.
In the context of GLM, we use nonlinear link functions to associate the nonlinear,
non-continuous response variable to the linear predictor wiT θ. Using the relations
defined above, the probability of each sample being in category j (j=1, 2, .., k) is
derived in equation 3.3 in which Φ represents cumulative distribution function of
standard normal distribution and πij is the probability of sample i being from
category j [1].
ζij = P (yi ≤ j) = P (li ≤ γj+1 ) = P (ei +wiT θ ≤ γj+1 ) = Φ(γj+1 −wiT θ) ; πij = ζij −ζij−1
(3.3)
In this way, the linear predictor wiT θ is linked to the multi-category response
variable yi . The function that links the linear predictor to the response variable is
called a link function and in the multinomial Probit model, this link function is
cumulative distribution of standard normal density as defined above [1, 60].
Bayesian Hierarchical model and prior distributions
A sparse Bayesian ordinal Probit model was implemented which takes into
account the ordinal nature of cancer progression stages and can accommodate
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large number of variables. We used independent double exponential prior
distributions on θj as follows [7, 67]. It should be noted that θj is the parameter
associated with gene j. This prior distribution has a spike at zero and light tails
which enables us to incorporate sparsity in terms of number of variables used in
√

the model [7, 107].
π(θj |λ) =

λ −√λ|θj |
e
2

(3.4)

The double exponential distribution can be represented as scale mixture of
normal with an exponential mixing density [7, 37, 67, 107]. This hierarchical
representation will be used in order to be able to set up the Gibbs
sampler [7, 67, 107].
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Having li ∼ N wiT θ, 1 , the following hierarchical prior distribution is used on
parameters associated with gene 1 to gene p [7].
 
λ
θj |ηj ∼ N (0, ηj ) ; ηj ∼ Exp
2

(3.6)

Defining the parameters as above, the hierarchical representation of the model
is as follows. li |θ ∼ N (wi T θ, 1) , θj |ηj ∼ N (0, ηj ) , and ηj ∼ Exp

λ
2


. We also

assume uniform priors on thresholds and we will find their fully conditional
posterior distribution alongside other parameters. Using the above mixture
representation for the parameters and defining prior distributions, we obtain the
following fully conditional posterior distributions that will be used in a simple Gibbs
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sampling algorithm.
li |− ∼ DT N (wiT θ, 1)

(3.7)

In formula 3.7, DTN stands for doubly truncated normal distribution. For
observation ‘i’ with yi = r, li must be sampled from normal distribution defined
above truncated between γr and γr+1 in each iteration of the algorithm.
θ|− ∼ M V N
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Fully conditional posterior distribution of vector of model parameters is
multivariate normal distribution with mean vector and variance covariance matrix
as specified where T = diag(η1 , η2 , .., ηp ). In 3.8, W is the n ∗ p matrix in which wij
represents expression level of gene j in ith sample and p is the number of genes
(variables) in the model and L = [l1 , l2 , . . . , ln ]T and ‘n’ is the number of samples.
The fully conditional distribution of hyper-parameters ηj−1 , j = 1, .., p are
√

inverse-Gaussian distribution with location

λ
|θj |

and scale λ. In each iteration of the

Gibbs sampling, ηj−1 is sampled from the inverse gaussian distribution defined in
equation 3.9.
ηj−1 |− ∼ inv − Gaussian

!
√
λ
,λ
|θj |

(3.9)

In the case of multinomial response, we assign independent uniform priors to
thresholds and thus the fully conditional distribution for thresholds is uniform
distribution and we need to sample them in each iteration of Gibbs sampling
alongside other parameters in the model [1].
γs |− ∝

n
Y

[I(yi = s − 1) ∗ I(γs−1 ≤ li < γs ) + I(yi = s) ∗ I(γs ≤ li < γs+1 )] (3.10)

i=1
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As explained in [1] , the conditional posterior distribution of γs can be seen to
be U nif orm(δ1 , δ2 ) in which δ1 = max [maxi [li |yi = s − 1] , γs−1 ] and
δ2 = min [mini [li |yi = s] , γs ], [1]. It should be noted that I() is indicator function
and its value is one if its argument is true and is zero otherwise. Figure 3
represents the Gibbs sampling algorithm workflow in a coherent way.
Dataset and feature selection
The method was applied to a published dataset on prostate cancer
progression downloaded from Gene Expression Omnibus at NCBI
(GSE6099) [90]. The data set contains gene expression values for 20,000 probes
and 101 samples corresponding to five prostate cancer progressive stages
(subtypes): Benign, prostatic intraepithelial neoplasia (PIN), Proliferative
inflammatory atrophy (PIA), localized prostate cancer (PCA), and metastatic
prostate cancer (MET) [90]. Since there were only two samples for PIA, we
removed these samples from further analysis. Probes with missing in more than
10 percent of the samples were removed from the data set. For the remaining
probes, the missing values were imputed by using the mean value of the probe
across samples with non-null values. Before applying our model to this data set,
for each gene we performed logistic regression for ordinal response. This method
enables us to take into account the ordinal nature of response variable in the
analysis and provides a gene list to be used as input to the model. Genes were
ranked based on the p-value associated with the hypothesis H0 : θi = 0 from the
most significant to least significant. θi is the parameter associated with gene i. We
performed Benjamini and Hochberg FDR correction [9]. An FDR cutoff value of
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0.05 resulted in a list of 398 genes. Thus, the input to our model was 398 variables
(genes) for 99 samples corresponding to four different prostate cancer subtypes.
The Gibbs sampling algorithm was implemented in R software and the program
ran for 60k iterations and the first 20k was discarded as burn-in.

Figure 3: Gibbs sampling algorithm flowchart for sparse Bayesian Generalized
Linear model utilizing Double Exponential prior and multinomial response.
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Evaluation
The dataset was randomly divided into training (N=50) and test (N=49) groups
such that each group contained an equal number of prostate cancer subtypes,
Benign, PIN, PCA and MET. Taking benign as an example, there are 34 benign
samples, we randomly divide it into two groups one half is used as part of the
training and the other half is hold out to be used as part of the test set for model
evaluation. The same procedure is repeated for PIN, PCA, and MET to obtain
complete train and test sets each having equal number of each subtype. Genes
were ranked based on posterior mean of parameters and the top 10 or 50 genes
obtained from the model were used for classification. In order to make the model
more robust we performed 50 re-samplings on selection of training and test
groups and re-ran the model. The average performance of SBGLM was compared
to two well-known classification methods: Support Vector Machine (SVM) and
Random Forrest. SVM was implemented in R software using Kernlab library [42]
and Random Forest was implemented in R using randomForest library [51].
Results
Figure 4 shows an example of the mean of posterior distribution of θ s
associated with 398 genes in a single run of SBGLM. We used the top 10 or 50
genes to test the classification accuracy of the SBGLM on 50 resampled training
and test groups. Each training and test group had an equal number of the four
prostate cancer subtypes: Benign, prostatic intraepithelial neoplasia (PIN),
localized prostate cancer (PCA), and metastatic prostate cancer (MET). We found
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Figure 4: Posterior mean of θ asociated with gene 1 to gene 398.
that the average overall classification accuracy of the SBGLM was 80.4 and 82.3
percent when using 10 and 50 marker genes, respectively (Table 4). The
performance of SBGLM approach was compared to two well-known classification
methods, SVM and Random Forest [12] when using top 10 or top 50 genes from
398 input genes. We found that the overall accuracy of SBGLM was substantially
better than SVM and was comparable, albeit slightly lower, to Random Forrest
when using either 10 or 50 marker genes.
It is important to note that the feature selection for SVM and Random Forests
was based on the p-values of the ordinal linear regression model (top 10 and top
50 from the 398 input genes). These results indicate that a small subset of the
398 input genes is better for predicting prostate cancer progression. Next, we
examined the performance of SBGLM with regard to classifying the different
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Table 4: Overall average accuracy of SBGLM, SVM and Random Forest using 10
and 50 marker genes.
Model
SBGLM
SVM
Random Forest

P=10
80.4(0.06)
53.6(2.7)
83(1.6)

P=50
82.3(0.063)
0.67(3.04)
84.6(2)

Table 5: Average classification accuracy of prostate cancer subtypes in the test
group using SBGLM, SVM and Random Forest with 10 marker genes.
Sample Type
Benign
PIN
PCA
MET

SBGLM
SVM
95.1(6)
84.4 (5.3)
61.7(2.8) 9(7.2)
86.9(1.1) 37.4(9)
56(3.2)
55.3 (1.2)

Random Forest
91.1(4.5)
61.4(1.9)
86.7 (2.1)
82.8(7.3)

subtypes of prostate cancer in comparison to SVM and Random Forrest (Table 5).
When using 10 marker genes, SBGLM classified all four subtypes of prostate
cancer more accurately than SVM, and it performed better than Random Forrest
for classifying Benign, PIN, and PCA. Interestingly however, when using 50
marker genes, SBGLM performed better than Random Forrest at classifying
Benign, PIN and MET(Table 6). These results indicate that the performance of
SBGLM is comparable to Random Forrest in classifying subtypes of prostate
cancer, although the results for both methods are sensitive to the number of
selected marker genes. Since the results of SBGLM were comparable to Random
Forrest, we next asked if SBGLM gene rankings were more or less relevant to the
biological mechanisms associated with prostate cancer progression. As a first
step in evaluating the biological relevance for the top ranked genes in the models,
we used a literature based method called GeneSet Cohesion Analysis Tool
(GCAT) [96].

47

Table 6: Average classification accuracy of prostate cancer subtypes in the test
group using SBGLM, SVM and Random Forest with 50 marker genes.
Sample Type
Benign
PIN
PCA
MET

SBGLM
SVM
Random Forest
99.6(1.9) 90.1(1.7) 96.8(1.3)
53.4(1.4) 38.2(8.2) 52(1.1)
65.4(7.2) 45.8(6.2) 84.8(5.4)
95.4(6.3) 81.8(1.6) 83.6(7.09)

GCAT is a web-based tool that determines the functional coherence p-values
of gene sets based on latent semantic analysis of Medline abstracts [96]. The
literature derived p-value is obtained by comparing distribution of gene similarities
for the gene set to the one obtained for a randomly selected genes from the whole
genome [96]. The small Lpv is an indication of functional cohesion of gene set.
Table 7 shows the average GCAT literature derived p-values (LPv) for the top 100
genes obtained from 50 runs of SBGLM and Random Forrest as well as the top
100 genes based on the p-value rank ordering of single gene analysis using
ordinal logistic regression. We found that on average, SBGLM produced more
functionally cohesive gene list (LPv = 0.007) compared to classical logistic
regression (LPv= 0.047) and Random Forest (LPv=0.131). Notably, 96 percent of
the runs had smaller LPv than 0.047, produced by initial p-value ranking. Based
on these results, we conclude that although SBGLM produces comparable
classification accuracy as Random Forrest, it identifies more biologically relevant
gene markers.
Discussion
Complex diseases and biological processes are caused by interaction of
multiple genes (gene products). Hence, current approaches which rely on single
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Table 7: Literature based functional cohesion p-values (LPv) of the top 100 genes
obtained from three different models.
Model
SBGLM
Classical Logistic regression
Random Forest

GCAT P-value
0.007 (0.001)
0.047
0.131(0.07)

variable analysis have limited utility in understanding molecular mechanisms and
identification of genetic biomarkers for classification of diseases [14, 21, 73].
Moreover, most genomic approaches collect data for a much larger set of gene
variables compared to the number of samples being investigated. Therefore,
highly regularized approaches, such as penalized regression models, are needed
to identify non-zero coefficients, enhance model predictability and avoid
over-fitting [107]. Lastly, continuous response variables which are a requirement
of linear regression methods are not applicable to response variables
(phenotypes) that are dichotomous or polytomous. To address these limitations,
we developed a sparse Bayesian multinomial model and evaluated its
performance using prostate cancer gene expression data. We found that the
SBGLM classification accuracy of prostate cancer subtypes were comparable to
Random Forrest. However, SBGLM identified more biologically relevant gene sets
(Table 7).
Based on these results, we posit that SBGLM may be a better approach to
simultaneously identify marker genes for classifications as well as gaining insights
into the molecular mechanisms of the phenotype under investigation.
Interestingly, using fewer genes, SBGLM had very good discrimination
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performance for classifying benign (99.6% accuracy) versus metastatic prostate
cancer (95.4% accuracy), but the model discrimination was weaker for PIN and
PCA (Table 5). These results are consistent with the previous observation that
PIN and PCA share markedly similar expression signatures [90]. We found that
increasing the number of marker genes to 50 does not improve discrimination
between PIN and PCA, suggesting that different molecular mechanisms may
underlie the progression of PIN to PCA.
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Chapter 4
A Robust Bayesian Approach for Inducing Sparsity in Generalized Linear
Models with Multi-Category Response
Abstract
The dimension and complexity of gene expression data obtained from
microarrays has created challenging data analysis problems. Specifically, large
number of genes to be analyzed compared to small number of samples is a major
limitation in expression profiling. This issue has attracted attention to shrinkage
and estimation methods. In this study, We utilized the Generalized Double Pareto
(GDP) prior to induce sparsity in Bayesian generalized linear models setting. GDP
while has a spike at zero like the double exponential density, it also has a Student
t-like tail behavior which helps us remedy over shrinkage of signals toward zero
and thus offers more robustness properties. A hierarchical Sparse Bayesian
Generalized Linear Model using GDP prior (SBGG) was developed in order to
facilitate Gibbs sampling which takes into account the progressive nature of the
response variable. Bayesian computation is straightforward via the simple Gibbs
sampling algorithm developed. The method was evaluated using a published
dataset (GSE6099) which contained 99 prostate cancer cell types in four different
progressive stages. Initially, 398 genes were selected using ordinal logistic
regression with a cut-off value of 0.05 after Benjamini and Hochberg FDR
correction. The dataset was randomly divided into training (N=50) and test (N=49)
groups such that each group contained equal number of each cancer subtype. In
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order to obtain more robust results we performed 50 re-samplings of the training
and test groups. We were able to achieve an average classification accuracy of
86% and 82.5% in training and test groups, respectively using only the top ten
genes obtained from SBGG. We functionally evaluated the model performance by
using a literature mining approach called Geneset Cohesion Analysis Tool.
Examination of the top 100 genes produced an average functional cohesion
p-value of 2.0E-4 compared to 0.007, 0.047, and 0.131 produced by Sparse
Bayesian Generalized Linear Model obtained by imposing double exponential
prior on parameters (SBGDE), classical multi-category logistic regression, and
Random Forest approaches, respectively. In addition, 100 percent of the SBGG
runs resulted in a GCAT literature cohesion p-value smaller than 0.047. Based on
our results, we conclude that the Bayesian Multinomial Generalized Linear model
applied to cancer progression data results in better subclass prediction and
produces more functionally relevant gene sets.
Background
Genomic research has benefited from microarray technology as a high
throughput discovery tool. In modern microarray experiments, expression levels of
several thousand of genes are measured across small number of samples
(usually less than100). The dimension and complexity of gene expression data
obtained from microarrays creates challenging data analysis problems. One of the
major challenges is related to the nature of microarray experiments having
substantially smaller number of samples compared to tens of thousands of
variabes. This is due to the fact that the very small sample size makes it very
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challenging to identify important genes among the pool of large number of genes
at hand [15]. Several statistical methods in univariate and multivariate analysis
frameworks have been developed to address this problem. Some of the univariate
analysis approaches applied to selection of important genes from microarray
experiments include t-test [46], regression modelling [50], mixture model [66] and
non-parametric methods [90, 91]. However, single gene analysis is unable to
identify weaker associations especially for complex polygenic phenotypes for
which the relevant variation is distributed across several variables [7]. In order to
address limitations of single variabe analysis methods, Several approaches for
simultaneous analysis of multiple variabes have been developed [53, 94, 98].
One of these classical techniques is linear regression. In a linear regression
framework, the least square method is used to obtain estimate of parameters. In
cohorts with large number of variabes compared to much smaller sample size,
parameter estimates based on ordinary least squares have high variances which
results in poor prediction accuracy [88]. Feature selection that can result in set of
genes with strongest effect and discriminating power is of high interest. Variable
selection in regression framework namely backward elimination, forward
selection, and stepwise selection have been used as a standard method to
improve parameter estimation and prediction. One of the shortcomings of these
methods is that these are discrete processes which are very sensitive to the
changes in the data at hand. That is, a minor change in data can result in very
different models [49, 88, 107]. Additionally, the computational complexity of these
approaches when the number of variabes are very large makes them less
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attractive for gene expression analysis [49, 88]. Moreover in this setting,
over-fitting is a major concern and may result in failure to identify important
predictors. Thus, the data structure of typical microarray experiments makes it
difficult to use traditional multivariate regression analysis [7].
Several groups have developed methods in an attempt to overcome these
drawbacks [49, 53, 94, 98, 108]. Various methods such as K-nearest neighbour
classifiers [90], linear discriminant analysis [99], and classification trees [90] have
been used for multi-class cancer classification and discovery [14, 20, 73].
However, gene selection and classification are treated as two separate steps
which can limit their performance. One alternative to deal with these situations is
using Generalized Linear Models (GLM) [58, 60, 62]. Scientist in many different
fields are faced with traits that are categorical such as normal and cancerous
tissues in case of binary traits and study of stages of cancer progression which
can have multiple categories. For situations with categorical phenotypes,
researchers have used GLM methodology for data analysis, prediction, and
classification. For typical microarrays, due to extensively large number of
variabes, the maximum likelihood estimates of parameters will become
computationally intensive and sometimes intractable. Additionally, since the
sample size is much smaller than number of variabes, the maximum likelihood
estimates may have large estimated variances and thus result in poor prediction
accuracy. The last but not least, maximization process may not converge to
maximum likelihood estimates [94]. It has been proposed that prediction accuracy
can be improved by setting the unimportant variabes to zero and thus obtaining
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more accurate prediction for the significant variabes [88].
In order to avoid over-fitting and improve model accuracy, models which
impose sparsity in terms of variables (genes) are desirable [88]. Least Absolute
Shrinkage and Selection Operator (LASSO) is a well-known method for inducing
sparseness in the model while highlighting the relevant variables [45, 88, 107]. A
Bayesian LASSO method was proposed by [37, 67] in which double exponential
prior is used on parameters in order to impose sparsity in the model. However,
these procedures may cause over-shrinking of large coefficients due to the
relatively light tails of the double exponential prior thus introducing major bias [58].
Using normal-Jeffreys prior which has heavier tails than double exponential
distribution, we would be able to shrink small coefficients to zero while minimally
shrinking large coefficients and thus obtaining better results. However it has no
meaning from an inferential aspect as it leads to an improper posterior [5]. An
alternative class of hierarchical priors proposed in [14] that uses Bayesian
adaptive Lasso with non-convex penalization. However, it lacks simple analytic
form. In [5] authors proposed the Generalized Double Pareto (GDP) prior
distribution. The properties of this distribution that makes it appealing include:
having a spike at zero alongside student-t like tails, simple analytic form and
yielding proper posterior. In addition, it resembles double exponential density in
the neighborhood of zero and has heavier tails compared to double exponential
remedying unwanted bias resulting from over shrinkage of parameters toward
zero [5]. In this article, for the first time- to the best of our knowledge- we integrate
GDP prior into the Bayesian generalized linear models framework dealing with
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multi-category ordinal response variables to induce sparseness in situations with
number of parameters to be predicted far exceeding the number of samples. The
model developed can be used to analyze multi-category phenotypes such as
progressive stages of cancer. In step one, we derive the fully conditional
distributions for all parameters in a multi-level hierarchical model in order to
perform the fully Bayesian treatment of the problem.
In the second step, the Markov Chain Monte Carlo (MCMC) method [30, 31]
based on Gibbs sampling algorithm is used to estimate all the parameters. This
model takes into account the progressive levels of the response variable. We
applied and evaluated our model to a publicly available prostate cancer
progression dataset [90]. Our study has 3 goals, testing if the model developed
can :1)result in a smaller subset of genes with high discriminating power, 2)
obtaining high classification accuracy; 3) in addition to above goals, we aim at
finding more biologically relevant genes related to phenotype under study
compared to competitive methods.
Methods
Let y1 , y2 , .., yn represent the observed response variables which can take
values 1, 2, 3, .., k where k is the number of categories of the ordinal response
variable. In addition, let wij represent the value of variabe ‘j’ in sample ‘i’. In the
case of gene expression analysis, gene expression levels are measured for each
sample and wij represents expression level of gene j in ith sample. We
implemented GLM for ordinal response in Bayesian framework by utilizing logistic
link function and careful introduction of latent variables [1]. In Bayesian framework
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joint distribution of all parameters is proportional to likelihood multiplied by prior
distributions on the parameters. The generic form of likelihood function for
Bayesian Multinomial model was represented in chapter 3 formula (3.1).
As explained in [1], in order to be able to set up the Gibbs sampler and
incorporate regression parameters into the model, we introduce 0 n0 independent
latent variables l1 , l2 , .., ln defined as li = wiT θ + ei and F (ei ) =

1
1+e−ei

[55]. In this

formula, wiT is the vector of gene expressions for individual i and θ = (θ1 , .., θp )
are parameters associated with variable 1 to p respectively. The relationship
between response variable and the corresponding latent variables are explained
in chapter 3 formula (3.2) [1]. In order to insure that the thresholds are identifiable,
following the guidelines of [1] we fix γ2 at zero and γ1 , and γk+1 are defined
according to equation (3.2). In the context of GLM, we use nonlinear link functions
to associate the nonlinear, non-continuous response variable to the linear
predictor wiT θ, [1, 62]. It should be noted that logistic distribution has heavy tails
and thus normal distribution does not provide a good approximation and hence
we used student-t distribution with v degrees of freedom on latent variables. We
treat the degrees of freedom as unknown and estimate it alongside other
parameters. Using the relations defined above, the probability of each sample
being in category j(j = 1, 2, .., k) is derived in equation (4.1) in which πij is the
probability of sample i being from category j [1].
ζij = P (yi ≤ j) = P (li ≤ γj+1 ) = P (wiT θ+ei ≤ γj+1 ) =

1
T

1 + e−(γj+1 −wi θ)

; πij = ζij −ζij−1
(4.1)
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In this way, the linear predictor, wiT θ, is linked to the multi-category response
variable yi . The function that links the linear predictor to the response variable is
called a link function and in the multinomial Logistic model, this link function is
cumulative distribution of standard Logistic density as defined above [1, 58, 60]
Prior distributions and Bayesian set up
A sparse Bayesian ordinal logistic model was implemented which takes into
account the ordinal nature of cancer progression stages and can accommodate
large number of variabes. In order to sample li from tv (wiT θ), we use the
hierarchical model represented in chapter 2 formula (2.3) which is equivalent to
sampling from the corresponding t-distribution [62]. This two-level hierarchical
form is easier to work with both analytically and computationally compared to the
original form of the t distribution [62]. We put independent generalized double
Pareto priors on all θ s as represented in formula (2.4) [5]. This prior distribution
has a spike at zero and light tails which enables us to incorporate sparsity in
terms of number of variabes used in the model [5]. WE put independent GDP
prior on all parameters as θj ∼ GDP (ζ = ρδ , ρ) independently. The joint distribution
of θs was obtained in chapter 2 formula (2.5).
GDP prior can be represented as a scale mixture of normal distributions
leading to computational simplifications that makes Gibbs sampling feasible. The
GDP ( ρδ , ρ) prior is equivalent to hierarchical representation presented in formula
(2.6) [5]. The hyper parameters ρ and δ control the shape of the GDP distribution
and thus the amount of shrinkage induced. As δ increases the distribution
becomes flatter and variance increases. As ρ increases the tails of distribution
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becomes lighter, variance becomes smaller, and the distribution becomes more
peaked. Thus, large values of ρ may cause unwanted bias for large signals and
stronger shrinkage for noise-like signals while larger values of δ flattens the
distribution and we may lose the ability to shrink noise-like signals. As mentioned
in [5], by increasing ρ and δ at the same rate the variance remains constant but
tails of the distribution becomes lighter converging to Laplace density in limit. This
can lead to over-shrinkage of coefficients that are away from zero. In the absence
of information on hyper parameters one can either set them to default values
(ρ = δ = 1) or choose a hyper prior distribution and let data speak about the
values of these hyper parameters.
We adopt the prior distributions defined in chapter 2 formulas (2.7) and (2.8)
for these parameters. The priors on ρ and δ correspond to generalized Pareto
priors with location parameter 0, shape parameter 1, and scale parameters c−1
and c0 −1 respectively. As mentioned in the formula (2.7) and formula (2.8), c and c0
determine the location of the median of the distribution of parameters ρ and δ .
For sampling purposes, we use the transformations presented in formula (2.9)
that lead to uniform prior distribution for the new parameters [5]. Defining the
parameters as above, the hierarchical representation of the model is as follows.

 2


λ
v v
1
T
li |λi , θ ∼ N wi θ, Λi , Λi ∼ Gamma 2 , 2 , θj ∼ N (0, τj ), τj ∼ Exp 2j ,
λj ∼ Gamma (ρ, δ), and we put noninformative uniform prior on v. Using the
above mixture representation for the parameters and defining the prior
distributions, we obtain following conditional posteriors that lead to a
straightforward gibbs sampling algorithm.
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li |− ∼ DT N (wi T θ,

1
)
Λi

(4.2)

In formula (4.2), DTN stands for doubly truncated normal distribution with
mean wiT θ and variance

1
.
Λi

For observation ‘i’ with yi = r, li must be sampled

from normal distribution defined above truncated between γr and γr+1 in each
iteration of the algorithm. In each iteration of Gibbs sampling procedure, θ is
sampled from the multivariate normal distribution with mean vector and variance
covariance matrix as derived in equation (2.11). The fully conditional posterior
distribtion for parameters [τj−1 ]nj=1 is Inverse Gaussian distribution defined in
equation (2.12). In each iteration of the Gibbs sampling, each λj and Λj is
sampled according to equation (2.13) and (2.14) respectively. The fully conditional
distributions for v,u1 , and u2 are represented in equations (2.15)-(2.17). As
explained in chapter 2, the fully conditional distributions of v, u1 , and u2 (formula
2.15-2.17) do not have closed form and thus we adopt the following embedded
giddy gibbs sampling to sample from v, ρ, and δ [5, 75]. On a grid of k values
(v1 , v2 , ..., vk ) representing all possible values of degrees of freedom we perform
the following procedure.
• Calculate the weights as ri = π(vi |−) according to formula 15.
• Normalize the weights ri N =

r
Pk i

i=1 ri

• Sample one value from (v1 , v2 , ..., vk ) with probabilities (r1 N , r2 N , ..., rk N ).
On a grid of values in interval (0, 1) we use the same procedure to sample one
value from u1 and u2 to use in the current iteration of Gibbs sampling. The only
difference is that at the end of the procedure we transform u1 and u2 back to ρ and
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δ using ρ = 1c [ u11 − 1] and δ =

1 1
[
c0 u2

− 1] respectively. In the case of multinomial

response, we assign independent uniform priors to thresholds and thus the fully
conditional distribution for thresholds is uniform distribution and we need to
sample them in each iteration of Gibbs sampling alongside other parameters in
the model [1]. The fully conditional distribution on thresholds is represented in
formula (3.10). Using equation (3.2), and (3.9), the conditional posterior
distribution of γs can be seen to be U nif orm(δ1 , δ2 ) in which
δ1 = max[maxi [li |yi = s − 1], γs−1 ] and δ2 = min[mini [li |yi = s], γs ]. It should be
noted that I() is indicator function and its value is one if its argument is true and is
zero otherwise. The Gibbs sampling procedure is explained in the flowchart
represented in figure 6.
Dataset and Feature Selection
The method was applied to a published dataset on prostate cancer
progression downloaded from Gene Expression Omnibus at NCBI
(GSE6099) [90]. The data set contains gene expression values for 20,000 probes
and 101 samples corresponding to five prostate cancer progressive stages
(subtypes): Benign, prostatic intraepithelial neoplasia (PIN), Proliferative
inflammatory atrophy (PIA), localized prostate cancer (PCA), and metastatic
prostate cancer (MET) [90]. Since there were only two samples for PIA, we
removed these samples from further analysis. Probes with null values in more
than 10% of the samples were removed from the data set. For the remaining
probes, the null values were imputed by using the mean value of the probe across
samples with non-null values. Before applying our model to this data set, for each
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Figure 5: Gibbs sampling procedure for SBGG model.
gene we performed logistic regression for ordinal response.
This method enables us to take into account the ordinal nature of response
variable in the analysis and prepare a gene list used as input to the model. Genes
were ranked based on the p-value associated with the hypothesis H0 : θi = 0 from
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the most significant to least significant. In here θi is the parameter associated with
gene i. We performed Benjamini and Hochberg FDR correction [9]. An FDR
cut-off value of 0.05 resulted in a list of 398 genes. Thus, the input to our model
was 398 variabes (genes) for 99 samples corresponding to four different prostate
cancer subtypes. The Gibbs sampling algorithm was implemented in R software
and the program ran for 60k iterations and the first 20k was discarded as burn-in.
Simulation and Cross validation procedure
The dataset was randomly divided into training (N=50) and test (N=49) groups
such that each group contained an equal number of prostate cancer subtypes
Benign, PIN, PCA and MET. Genes were ranked based on posterior mean of
parameters and the top 10 or 50 genes obtained from the model were used for
classification. In order to make the model more robust, we performed 50
re-samplings on selection of training and test groups and re-ran the model. The
average performance of SBGG was compared to three well-known classification
methods: Support Vector Machine (SVM), Random Forrest, and Sparse Bayesian
Generalized Linear Model obtained imposing double exponential prior (SBGDE)
on parameters. SVM was implemented in R software using Kernlab library [42]
and Random Forest was implemented in R using randomForest library [51], We
implemented the SBGDE according to [57, 58] in R software.
Results
Figure 6 shows an example of the mean of posterior distribution of θ s
associated with 398 genes in a single run of SBGG. We used the top 10 or 50
genes to test the classification accuracy of the SBGG on 50 resampled training
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and test groups. In order to have a balanced data set, each training and test
group had an equal number of the four prostate cancer subtypes: Benign,
prostatic intraepithelial neoplasia (PIN), localized prostate cancer (PCA), and
metastatic prostate cancer (MET). We found that the average overall classification
accuracy of the SBGG was 82.5% and 94.2% when using 10 and 50 marker
genes, respectively (Table 8). Three well known classification methods namely,

Figure 6: Posterior mean of θ asociated with gene 1 to gene 398 obtained from
Gibbs Sampling.

Random Forest [12], Support Vector Machine(SVM) [43], and SBGDE [56] were
implemented and the classification results were compared to our model. We found
that the overall accuracy of SBGG was substantially better than SVM and SBGDE
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Table 8: Overall average accuracy of SBGLM, SVM and Random Forest using 10
and 50 marker genes.
Model
SBGG
SBGDE
SVM
Random Forest

P-10
82.5(0.55)
80.4(0.06)
53.6(2.7)
83(1.6)

P-50
94.9(3.08)
82.3 (0.063)
67(3.04)
84.6(2)

when using top 10 and top 50 genes for classification. Table 8, shows that when
using 10 marker genes, Random Forest performs slightly better than SBGG (0.5%
higher average classification accuracy). However when using 50 marker genes,
SBGG achieves measurably higher classification accuracy than Random Forest.
It is important to note that the feature selection for SVM and Random Forests
was based on the p-values of the ordinal linear regression model (top 10 and top
50 from the 398 input genes). These results indicate that a small subset of the
398 input genes is better for predicting prostate cancer progression. Next, we
examined the performance of SBGG with regard to classifying the different
subtypes of prostate cancer in comparison to SVM, Random Forrest, and SBGDE
(Table 9, and Table 10). When using 10 marker genes, SBGG classified all four
subtypes of prostate cancer more accurately than SVM, and it outperformed
SBGG for classifying PIN, PCA, and MET. It also performed better than Random
Forrest for classifying PIN, and PCA. Interestingly however, when using 50 marker
genes, SBGG performed substantially better than SVM in classifying all tumor
subtypes and outperformed SBGDE in classifying PIN and PCA samples. SBGDE
performed slightly better that SBGG for classifying benign samples using 50
marker genes. Comparison of classification results to Random Forrest shows that
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Table 9: Average classification accuracy of prostate cancer subtypes in the test
group using SBGG, SBGDE, SVM, and Random Forrest models with 10 marker
genes.
Sample Type
Benign
PIN
PCA
MET

SBGG
89.4(6.1)
62.5(1.6)
98.7(0.7)
59.4(2.06)

SBGDE
95.1(6)
61.7(2.8)
86.9(1.1)
56(3.2)

SVM
84.4(5.3)
9 (7.2)
37.4(9)
55.3(1.2)

Random Forest
91.1(4.5)
61.4(1.9)
86.7(2.1)
82.8(7.3)

Table 10: Average classification accuracy of prostate cancer subtypes in the test
group using SBGG, SBGDE, SVM, and Random Forrest models with 50 marker
genes.
Sample Type
Benign
PIN
PCA
MET

SBGG
95.4(3.07)
80.6(0.08)
98.9(1.9)
96.8(4.6)

SBGDE
99.6(1.9)
53.4(1.4)
65.4(7.2)
95.4(6.3)

SVM
90.1(1.7)
38.2(8.2)
45.8(6.2)
81.8(1.6)

Random Forest
96.8(1.3)
52(1.1)
84.8(5.4)
83.6(7.09)

SBGG outperforms Random Forest in all categories except benign for which
Random Forest achieves slightly better accuracy.
These results indicate that the performance of SBGG is comparable to
Random Forrest in classifying subtypes of prostate cancer and slightly better,
although the results for both methods are sensitive to the number of selected
marker genes. Since the results of SBGG were comparable to Random Forrest,
we next asked if SBGG gene rankings were more or less relevant to the biological
mechanisms associated with prostate cancer progression. As a first step in
evaluating the biological relevance for the top ranked genes in the models, we
used a literature based method called GeneSet Cohesion Analysis Tool
(GCAT) [96]. GCAT is a web-based tool that determines the functional coherence
p-values of gene sets based on latent semantic analysis of Medline abstracts [96].
Table 11 shows the average GCAT literature derived p-values (LPv) for the top
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Table 11: Literature based functional cohesion p-values (LPv) of the top 100 genes
obtained from three different models.
Sample Type
SBGG
SBGDE
Classical Logistic Regression
Random Forest

Lpv
2.0E-4(1.7E-5)
0.007(0.001)
0.047
0.131(0.07)

100 genes obtained from 50 runs of SBGG, Random Forrest, SBGDE as well as
the top 100 genes based on the p-value rank ordering of single gene analysis
using ordinal logistic regression. We found that on average, SBGG produced
more functionally cohesive gene list (LPv = 2.0E-4) compared to SBGDE
(LPv=0.007), classical logistic regression (LPv= to 0.047) and Random Forest
(LPv=0.131). Notably, 100% of the runs had smaller LPv than 0.047, produced by
single gene analysis using classical logistic regression p-value ranking. The
Literature p-value for the median run was 4.50E-06 compared to 1.90E-04 for
SBGDE and 2.85E-02 For Random Forest.
Discussion
Complex disease and biological processes are polygenic and caused by
interaction of multiple gene products. Hence, single gene analysis approaches
utility is limited in understanding complex molecular mechanisms and
identification of genetics biomarkers for classification of diseases [21, 31, 73].
Additionally, large number of genes collected compared to small number of
samples in microarray experiments makes the data analysis, feature extraction
and prediction quite challenging. In the situations that we are faced with fat
datasets with p >> n, highly regularized approaches, such as penalized
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regression models, are needed to identify non-zero coefficients, enhance model
predictability and avoid over-fitting [70]. The Bayesian Lasso which is a Bayesian
version of L1 penalized regression is such one of the most popular techniques.
However, this procedure inherits the problem of over-shrinking of large
coefficients due to the relatively light tails of the double exponential prior and may
miss some of the important factors in the model. Recently, the Generalized
Double Pareto (GDP) prior distribution was proposed as an alternative to induce
sparseness in situations when we are faced with large number of variabes
compared to sample size [5]. The authors applied the proposed method in the
normal linear regression model framework. This prior has a simple analytic form,
yields a proper posterior and possesses appealing properties, including a spike at
zero, Student t-like tails, and a simple characterization as a scale mixture of
normals leading to a straightforward Gibbs sampler for posterior inferences that
makes Bayesian shrinkage estimation and regularization feasible [5]. Utilizing this
prior in a more general framework of generalized linear models, we presented a
Bayesian hierarchical model to simultaneously fit and estimate all variabes in p »
n situations. While shrinking small effects toward zero and producing sparse
solutions, the over shrinkage problem caused by using light-tailed priors would be
remedied by the heavier tails obtained via mixing over the hyper parameters. We
developed a sparse Bayesian multinomial model and evaluated its performance
using prostate cancer gene expression data. We employ latent variables which
are distributed as student-t distribution to account for heavy tails of logistic
distribution to specialize the model to a regression model.
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We fit the model in a fully Bayesian approach, employing the MCMC algorithm
to generate posterior samples from the joint posterior distribution, which can be
used to make various posterior inferences. The Bayesian algorithm developed
treats all parameters as unknown including hyper parameters associated with the
GDP hierarchical representation and generates their posterior samples alongside
other parameters. We used the model to do prediction of tumor type on the test
dataset. The Bayesian set up enables us to assign the tumors to one of the
categories in a coherent way. In addition, we obtain the probability of each tumor
belonging to one of the categories that is much more meaningful than hard rules
of assignment that use 0 or 1 to correspond to being in a special category or not.
Also, we use small number of genes to do the prediction which simplifies the
experimental procedure.
We compared the model performance to three well known models: random
forests, SVM, and SBGDE. The average classification accuracy of SBGG using
10 marker genes was higher than SBGDE and SVM and was only 0.5% lower that
Random Forest. However, when using 50 marker genes it outperforms all the
three other methods (Table 9 and Table 10). We found that the SBGG
classification accuracy of prostate cancer subtypes were comparable to Random
Forrest when using 10 marker genes for classification and it outperforms Random
Forest in 3 out of four categories when we used 50 marker genes. Additionally, it
outperforms SBGDE in 3 out of 4 categories when using 10 marker genes for
classification and 3 out of 4 categories when using 50 marker genes.
Furthermore, SBGG identified more biologically relevant gene sets (Table 11).
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Based on these results, we posit that SBGG may be a better approach to
simultaneously identify marker genes for classifications as well as gaining insights
into the molecular mechanisms of the phenotype under investigation.
Interestingly, using fewer genes, SBGG had very good discrimination performance
for classifying benign (89.4% accuracy) versus PCA (98.7% accuracy), but the
model discrimination was weaker for PIN and MET (Table 2). These results are
consistent with the previous observation that PIN and PCA share markedly similar
expression signatures [90]. Random Forests are an ensemble method for
classification that has been shown to have good performance in many
bioinformatics applications. However, Random Forrest is prone to over-fitting in
datasets with noisy classification tasks. In addition, it is very hard to interpret the
classifications made by Random Forests. Furthermore, if data contain categorical
variables with different number of levels, Random Forest favors variables with
more levels, making the variable importance measures unreliable [11].
Conclusion
It is important to note that the classification accuracy of all three models were
compared using a selected set of 398 genes which were obtained based on
p-value of single gene analysis using an ordinal regression model. Hence, this
biases the initial gene selection process. It is possible that some biologically
relevant genes to the prostate cancer progression might have been missed by this
analysis due to low signal. One way to perform an initial gene selection could be
to consider gene pathway information as described previously by others [81].
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Chapter 5
Evaluation of literature aided variable selection in classification and feature
prioritization
One of the fundamental tasks in biomedical research is analysis of
gene-disease association. A major source to achieve this goal is examination of
Microarray data due to relatively low cost. Since a large number of genes are
typically involved with possible interactions, the association of genes with
diseases is very complicated. Methods employed for gene ranking(gene
prioritization) are based on statistical or knowledge based approaches to find
genes most likely associated with a given disease [41, 76]. Technical and
biological variability are the main causes of the noisy nature of gene expression
data which makes their analysis complex. This makes prediction methods aimed
at obtaining gene disease associations often less that adequate [68]. Even with
reliable gene expression data, statistical analysis of that data remains largely
challenging [97]. Normally, gene expression data are ranked by the strength of
the signal compared across disease and control tissues. Several studies have
aimed at comparing the results of multiple studies of the same genes and have
found little correlation between results [29]. Several factors contribute to this issue
including individual variation, different gene activation cycles, and variations in
protocols used to prepare the tissues [25]. Biomedical literature can be used as
an informative way to obtain the relevance of genes to different diseases. One
caveat of this method is that many genes from poorly studied organisms are not

71

well defined in literature. Additionally, a comprehensive summarization of the
literature attached to genes of different organisms is a challenging task [28].
Another fundamental task in biomedical research is regarding cancer
classification. Cancer research is one of the major areas in medical fields. It is
clear that prediction of different tumor types with high accuracy offers the
advantage of providing better treatment and reducing toxicity in the patients. In
the past, cancer classification has majorly been based on morphological and
clinical experiments. It has been reported that these methods have limited
diagnostic ability due to their several limitations [6]. Gene expression data can
provide the key for addressing the fundamental issues relating to cancer
diagnostics and drug discovery [54]. The main two aspects of cancer
classification is classification accuracy and ability to reveal meaningful gene
information. The high dimensionality of gene expression data(tens of thousands
of genes) compared to very small sample sizes (usually below 100) makes cancer
classification a daunting task. Another issue is that most genes are irrelevant to
the cancer classification task at hand. Additionally, it is very common for highly
differentially expressed genes not to be relevant to the disease under
study [35, 54]. Some researchers proposed to perform gene selection prior to
applying cancer classification methods. This step will help in reducing the data
size and thus improving the running time of the classification algorithm.
Additionally, another issue concerning cancer classification is statistical
significance versus biological relevance of cancer classifiers [54]. Most cancer
classification methods available are from statistical and machine learning area
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ranging from parametric methods such as generalized linear models to
nonparametric methods such as nearest neighbor analysis and support vector
machines [54]. One common aspect of most of these methods used in cancer
classification is that the primary goal of authors is classification accuracy and they
are less concerned with biological relevance [54]. This is due to the fact that most
classifiers are built based on strong signals or differentially expressed genes
across sample types. However, the majority of cancer related genes might not be
highly differentially expressed and thus the classifiers obtained based on
differentially expressed genes across different sample types might not reveal
biologically relevant genes. Gene selection methods that are based on signal
strength and differentially expressed genes, choose genes that are highly
differentially expressed across different tissue types, i.e. cancer and normal tissue
that might not necessarily be related to cancer.
GeneIndexer
Literature information can be used to select biologically relevant genes from
gene expression data in order to build cancer classifiers. This method can
potentially be very helpful in order to highlight the biological relevance of
classifiers built based on gene expression data. Here we investigate a very
famous gene ranking method based on biological literature called Gene
Indexer [39]. Gene Indexer utilizes Latent Semantic Indexing (LSI), a vector space
model for information retrieval, to automatically identify conceptual gene-gene and
gene-disease relationships from titles and abstracts of MEDLINE citations [39].
This method has proved to identify gene-keyword and gene-gene relationships
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with high average accuracy. Additionally, this method is able to obtain implicit
relationships between genes and keywords that proves very helpful in identifying
conceptual relationships [39].
Front-end Gene Selection Using Gene Indexer
We used Gene Indexer to obtain the input gene list to our models and other
classifiers built in previous chapters. For the leukemia data set of Golub et al used
in chapter 2 [32], the “leukemia” keyword was used to obtain literature correlation
of genes with leukemia. Genes were ranked based on their literature correlation
and the top 500 genes were used as input to the models. This data set consisted
of 72 samples obtained from Golub et al. [32]. In the Golub data set, the bone
marrow or peripheral blood samples from 72 patients with either acute
lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) were collected.
The gene expression levels for 7129 human genes were measured for this cohort.
We then extract these gene expressions from the data set and use them as input
to the classifiers. The data set was randomly divided into train and test data sets
of size 37 and 35 respectively. The training data sets contained 24 ALL and 13
AML samples and test data set contains 23 ALL and 12 AML samples. Genes
were ranked based on the posterior mean of parameters and the top 10 genes
obtained from the model were used for classification. In order to make the model
more robust, this process is repeated 50 times and the average classification
accuracy on training and test samples are reported.
The second data set used was the prostate cancer progression dataset
downloaded from Gene Expression Omnibus at NCBI (GSE6099) [90]. The data
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set contains gene expression values for 20,000 probes and 99 samples
corresponding to four prostate cancer progressive stages (subtypes): Benign,
prostatic intraepithelial neoplasia (PIN), localized prostate cancer (PCA), and
metastatic prostate cancer (MET) [90]. For this data set, we used the “prostate
cancer” keyword to obtain literature correlation of genes with “prostate cancer”.
The gene expressions corresponding to the top 500 genes were extracted from
the data set and used as input to the classifiers. The dataset was randomly
divided into training (N=50) and test (N=49) groups such that each group
contained an equal number of prostate cancer subtypes Benign, PIN, PCA and
MET. Genes were ranked based on posterior mean of the parameters and the top
10 genes obtained from the model were used for classification. In order to make
the model more robust we performed 50 re-samplings on selection of training and
test groups and re-ran the model. The average performance of SBGG was
compared to three well-known classification methods: Support Vector Machine
(SVM) [85], Random Forrest [40], and Sparse Bayesian Generalized Linear Model
obtained imposing double exponential prior (SBGDE) on parameters. SVM was
implemented in R software using Kernlab library [42] and Random Forest was
implemented in R using randomForest library [51], We implemented the SBGDE
according to [57] in R software.
Classifiers based on GeneIndexer and signal strength input gene lists
Table 12 represents the classification accuracy obtained for the binary
classifiers built for the leukemia data set. In this table, SBGG represents Bayesian
Generalized model built using Generalized double Pareto prior, “SBGDE” is the
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Table 12: Average Classification accuracy, Sensitivity, and specificity for test
groups.
Model
SBGG
SBGG
SBGDE
SBGDE
SVM
SVM
Random Forest
Random Forest

Gene Selection
Diff expression
GeneIndexer
Diff expression
GeneIndexer
Diff expression
GeneIndexer
Diff expression
GeneIndexer

Accuracy
94.1(3.05)
87.3(6.6)
91.2( 10.8)
81(7.09)
63(13)
69.1(8)
93(4.2)
88(2.7)

Sensitivity
Specificity
0.95(0.04)
0.93(0.029)
0.9(0.054)
0.79(0.073)
0.95(0.12)
0.86(0.098)
0.85(0.052) 0.71(0.09)
0.7(0.16)
0.5(0.11)
0.75(0.03)
0.57(0.11)
0.9(0.036)
0.93(0.048)
0.85(0.019) 0.93(0.035)

Table 13: Average classification accuracy of prostate cancer subtypes in the test
group using SBGG, SBGDE, SVM, and Random Forest.
Sample Type
Benign
Benign
PIN
PIN
PCA
PCA
MET
MET

Gene Selection
Diff expression
GeneIndexer
Diff expression
GeneIndexer
Diff expression
GeneIndexer
Diff expression
GeneIndexer

SBGG
89.4(6.1)
72(2.9)
62.5(1.6)
73(6.3)
98.7(0.7)
87(1.4)
59.4(2.06)
48(7.2)

SBGDE
SVM
95.1(6)
84.4(5.3)
51(10.04) 83(1.2)
61.7(2.8) 9.0(7.2)
66 (5.1)
13(8.6)
86.9(1.1) 37.4(9)
69(2.3)
37.4(5.2)
56 (3.2)
55.3(1.2)
44 (2.5)
37 (6)

Random Forest
91.1(4.5)
88(1.08)
61.4(1.9)
60.3(2.3)
86.7(2.1)
84.7(1.7)
82.8(7.3)
54(9.3)

classifier build using Double exponential prior, SVM is the classifier based on
support vector machines and the last classifier is build based on Random Forests.
Table 13 represent the classification accuracy of multi-category classifiers built on
prostate cancer progression data set. The values in this table show the average
classification accuracy on the test data set for multi-category GDP model
(SBGG), sparse Bayesian Generalized linear model developed using double
exponential prior (SBGE), Support Vector Machine model (SVM), and Random
Forest model. The input gene selection is done in two different scenarios: the
p-value rank ordering of single gene analysis using ordinal logistic regression and
top Genes obtained from GeneIndexer.
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Results and Discussion
Table 12 represents the classification accuracy, sensitivity, and specificity
measures for the sparse Bayesian Generalized linear model based on generalized
double Pareto prior ( SBGG), sparse Bayesian Generalized linear model based on
double exponential prior (called SBGDE), Support Vector Machine model (SVM),
and the model based on Random Forests (Random Forest). As we can see the
classifiers built based on input gene list obtained from differential expression
p-value ranking obtain higher classification accuracy, sensitivity, and specificity
than the rankings based on GeneIndexer in the majority of the classifiers. In the
GDP model, the classification accuracy and sensitivity and specificity is close for
the two paradigms. For the SVM model, the support vector machine obtains
higher classification accuracy, sensitivity, and specificity when using Gene Indexer
as input gene selection. For the Random Forest model the classification accuracy
in both paradigms are very close to each other. All in all the classifiers built on
highly differentially expressed genes obtain higher classification accuracy
compared to the Gene Indexer input gene list counterparts.
Table 13 represents the average classification accuracy for the multi-category
classifiers built on prostate cancer progression data sets. The four models
developed are the Sparse Bayesian Generalized Linear model based on
generalized double Pareto prior(SBGG), Sparse Bayesian Generalized Linear
model based on double exponential prior (SBGDE), the Support Vector Machine
model, and Random Forest model. For the Benign, sample type the models that
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are built based on input gene list obtained using single gene analysis using
ordinal logistic regression outperform the counterparts built upon the input gene
list obtained from Gene Indexer. For the PIN sample type, the models based on
Gene Indexer outperform their counter parts for SBGG, SBGDE, SVM and the
classification accuracy is a bit lower for the Random Forest model but comparable
for the two scenarios. For the PCA sample type, the models based on ordinal
logistic regression input gene list outperform the gene Indexer input gene list
models in 3 out of four models namely, SBGG, SBGDE, and Random Forest and
it has slightly lower classification accuracy for the SVM model. For the MET
sample types, the models based on ordinal logistic regression input gene lists
outperform all the models built based on Gene Indexer input gene list.
Even though the classifiers built based on the GeneIndexer gene selection
paradigm come close in classification accuracy, sensitivity, and specificity to their
counterparts for some of the classifiers, in majority of the classifiers, the gene
selection based on signal strength results in higher accuracy, sensitivity, and
specificity. One of the main reason for this phenomena is that the majority of
cancer related genes are not highly differentially expressed across different tissue
types which lowers their ability to be highly powerful predictors. On the other
hand, gene selection methods that are based on signal strength and differentially
expressed genes choose genes that are highly differentially expressed across
different tissue types, i.e. cancer and normal tissue. However, most of these
genes can be housekeeping genes or genes that are differentially expressed
during different cell cycles that might not be necessarily related to cancer.
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Thus, the classifiers obtained based on differentially expressed genes across
different sample types might not reveal biologically relevant genes. Thus, even
though these models obtain higher classification accuracy, they suffer from the
fact that they do not obtain comprehensive biological relevance in the set of
predictors obtained. Reduction in uncertainty due to technical and biological
variability through more comprehensive and unified tissue preparation and
experimentation can bridge the gap between classification accuracy and
biological relevance in cancer analytics and obtain more informative machine
learning models in cancer diagnostic and therapeutics. Another important issue is
that using an input gene list solely based on current literature hugely biases the
downstream results due to the fact that it ignores the signals coming out of the
experiment. Ideally, we would want signals coming from the experiment have
greater weight but have a technique to prioritize and tune these signals based on
biological information from literature.
In chapter 6, we develop a literature aided Sparse Bayesian Generalized
Linear Model (LSBGG) which can incorporate literature information in the form of
prior knowledge in tuning the prior distribution imposed on parameters. This way
we are able to take into account the biological relevance of markers to guide the
amount of shrinkage imposed in the model. Thus, we would be able to potentially
bridge the gap between classification accuracy and biological relevance and
obtain a set of markers which have high diagnostic capability based on more
biological relevance to phenotype under study.
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Chapter 6
Development of Literature Aided Bayesian Sparse Generalized Linear ModelBridging Classification Accuracy and Biological Relevance
Abstract
Gene expression profiling has two major limitations that offset their statistical
performance. Firstly, large numbers of variables are assessed compared to
relatively small sample sizes. Secondly, identification of a set of biologically
relevant markers with high predictive power remains difficult. Several machine
learning algorithms have been used for cancer classification which are geared
toward obtaining high classification accuracy and do not take into account the
biological relevance of the markers obtained. Thus, in the majority of applications,
markers found do not convey meaningful biological information and are merely
good classifiers. A machine learning schema that is able to bridge classification
accuracy and biological relevance will be of high merit to the community and can
potentially result in deeper understanding of the mechanisms involved. In this
study, we developed a Literature aided Sparse Bayesian Generalized Linear
model which utilizes Generalized Double Pareto prior (LSBGG) to induce
shrinkage in terms of the number of variabes. Additionally, instead of uninformed
hyper parameters for the prior distributions, we adopt a literature informed
approach to adjust the hyper parameters based on a marker’s biological relevance
to the phenotype under study. This will aid us in controlling shrinkage imposed on
genes based on their biological relevance.
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The method was applied to the leukemia data set of Golub et al. (1999). The
data set was randomly divided into train and test samples of sizes 37 and 35
respectively and classification performance on the test group was evaluated. We
performed 50 resamplings on the training and test groups. The top 500 highly
differentially expressed genes obtained were used for the modeling step. Using
the top 10 genes obtained from our model, we were able to achieve 96% average
classification accuracy. Additionally average sensitivity and specificity of 97% and
93% was achieved across the 50 runs. The model without incorporation of
biological information (SBGG) achieves averages of 87%, 92%, and 83%
accuracy, sensitivity, and specificity respectively. Additionally, There were 41
genes common in all 50 runs for the literature aided model compared to only 6
common genes for the model with uninformed choice of hyper parameters. This
results suggest that the literature model results in more consistent results with
significantly higher biological relevance. Taken together, these results suggest
that the literature informed Sparse Bayesian Generalized Linear Model applied to
leukemia data sets allows for better subclass prediction based on more
functionally relevant gene sets.
Introduction
The ability of cost-efficient gene expression analysis brings the possibility of
studying the relationship between complex traits or diseases and genes across
the entire human genome. Microarray studies usually include tens of thousands of
genes assayed for a few number of experimental units [19]. The widely applied
methods for analyzing gene expression data are based on single marker analysis
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in which the association of each gene to the traits are analyzed
independently [21, 66, 87, 91]. However, these methods are not capable of
capturing variance present in the polygenic phenotypes arising from several
variabes in a complex system [7]. Due to this limitation, simultaneous analysis of
genes has received more attention recently [53, 94, 98]. There are two main
challenges in developing methods for simultaneous analysis of genes in gene
expression data. Firstly, the large disparity between the number of variables and
the number of observations in the model reduces the accuracy of the prediction
and selection.
Another challenge in gene expression analysis is identification of a set of
biologically relevant markers with high predictive power. For example several
machine learning algorithms have been used for cancer classification which are
geared toward obtaining highest classification accuracy and do not take into
account the biological relevance of the markers obtained. Thus, in majority of
applications markers found do not convey meaningful biological information and
are merely good classifiers. Thus, a machine learning schema that is able to
bridge classification accuracy and biological relevance will be of high merit to the
community and can potentially result in deeper understanding of the mechanisms
involved. This is especially crucial when the goal of data analysis is the
identification of highly accurate but small panels of biomarkers with potential
clinical utility [82]. For large-scale problems with p»n, in linear regression, there is
a mass of literature in both frequentist and Bayesian framework. Frequentists
methods impose constraints on the size of the coefficients known as penalization.
82

The most popular one is the L1 norm penalty called Lasso introduced by
Tibshirani [88].
A commonly used method for imposing shrinkage in the Bayesian framework
is achieved by imposing prior distributions centered around
zero [5, 7, 34, 37, 49, 67]. In the majority of these methods the rate of
shrinkagemay not be desirable due to the fact that the same rate of shrinkage is
imposed on all parameters and all the coefficients are shrunk with the same rate.
Literature based association of markers to the trait are not taken into account by
these models which does not allow the capture of the comprehensive picture of
disease phenotype. Due to this limitation, only partial information is gained from
the biological stand point. Thus, a machine learning schema that is able to bridge
classification accuracy and biological relevance can potentially result in deeper
understanding of mechanisms involved.
A more desirable penalization method would be one that incorporates
literature information into the prior distribution by imposing different rates of
shrinkage, is obtained by adjusting the shape of the prior distribution on
parameters. In this study, we developed a literature aided Bayesian Shrinkage
Generalized Linear model which utilizes Generalized Double Pareto prior
(LSBGG) to induce shrinkage in terms of the number of variabes. Instead of
uninformed hyper parameters for the prior distributions, we adopt a literature
informed approach to adjust the hyper parameters based on the marker’s
biological relevance to the phenotype under study. This will aid us in guiding
shrinkage imposed on genes based on their biological relevance. This way we are
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able to impose different degrees of shrinkage adjusted based on literature
association of marker to the phenotype under study. We applied our method to
the leukemia data set of Golub et al. [32].
Methods
Let y1 , y2 , ..., yn represent the observed response variables in which 0 n0 is the
number of observations (samples). Here, yi can take on 0 or 1 if for example the
sample is normal or cancer respectively. In the case of gene expression analysis,
gene expression levels are measured for each sample and we let wij represent
the expression level of gene j in the ith sample. We use a logistic link function
introduced in formula (2.1) and (2.2) to associate the probability of belonging to
one of the categories to the linear combination of variabes. As explained in [1], in
order to be able to set up the Gibbs sampler, we introduce 0 n0 independent latent
variables l1 , l2 , ..., ln with li ∼ tv (wi T θ) where li ≥ 0 if yi = 1 and li < 0 if yi = 0.
This approach connects the logistic regression for yi to a linear regression model
for the latent variable li , [1]. It should be noted that the logistic distribution has
heavy tails and thus the normal distribution does not provide a good
approximation. Hence, we used student-t distributions with v degrees of freedom
on latent variables, li ∼ tv (wi T θ) [61]. We fix the degrees of freedom at 9 as the
t-distribution with 9 degrees of freedom closely approximates logistic
distribution [61].
Prior Distributions and Hyper Parameter Settings
In order to sample li from tv (wi T θ), we use the hierarchical model of formula
(2.3) which is equivalent to sampling from the corresponding t-distribution. This
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two-level hierarchical form is easier to work with both analytically and
computationally compared to the original form of the t distribution [34]. This two
level hierarchical distribution enables us to obtain closed forms for fully conditional
posterior distributions on parameters. We put independent generalized double
Pareto priors on all θ s as defined in formula (2.4) [5]. As mentioned in chapter 2,
GDP prior can be represented as a scale mixture of normal distributions leading
to computational simplifications that makes Gibbs sampling feasible. The


δ
GDP ρjj , ρj prior is equivalent to the following hierarchical representation [5].

θj |τj ∼ N (0, τj ); τj ∼ Exp

λj 2
2


; λj ∼ Gamma(ρj , δj )

(6.1)

The hyper parameters ρj and δj control the shape of the GDP distribution and
thus the amount of shrinkage induced. As δj increases the distribution becomes
flatter and variance increases. As ρj increases the tails of distribution becomes
lighter, variance becomes smaller, and the distribution becomes more peaked.
Thus, large values of ρj may cause unwanted bias for large signals and stronger
shrinkage for noise-like signals while larger values of δj flattens the distribution
and we may lose the ability to shrink noise-like signals. Here, we use literature
information to guide the choice of hyper parameters ρj and δj . We divided the
genes into 5 bins using quantiles of literature correlation of genes to 5 groups
(0-20 percentile, 21-40 percentile, 41-60 percentile, 61-80 percentile, and 81-100
percentile). Genes on the higher percentiles have higher correlation to the cancer
query. We set ρj = 1 if the literature correlation for a gene is located in the highest
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bin and set ρj = 1.4, 1.6, 1.8, 2 if the gene is located in 61 − 80, 40 − 60, 21 − 40,
and 0 − 20 percentiles respectively and we set δj = 1. This way we are able to
incorporate biological knowledge and control the amount of shrinkage imposed on
each gene based on the association of the gene to the phenotype under study.
Figure 7 represents this choice of prior distributions on parameters. Figure 8

Figure 7: Literature based GDP Prior.

shows a zoomed-in view of tail behavior of these distribution in order to
demonstrate the tail behaviors more clearly.
86

Figure 8: Tail behavior for literature based GDP Prior.

Fully Conditional Posterior Distributions
Defining the parameters as above, the hierarchical representation of the model



1
T
is as follows. li |λi , θ ∼ N wi θ, Λi , Λi ∼ Gamma v2 , v2 , θj ∼ N (0, τj ),
 2
λ
τj ∼ Exp 2j , λj ∼ Gamma (ρj , δj ). Using the above mixture representation for
the parameters and defining the prior distributions, we obtain conditional
posteriors as derived in formulas (2.10)- (2.12) for li , θ, and τj−1 respectively
leading to straight forward Gibbs sampling algorithm. Each λj is sampled
according to the fully conditional distribution defined in formula (6.2) and Λj is
sampled according to equation (2.14).
λj |− ∼ Gamma (ρj + 1, |θj | + δj ) ; j = 1, .., p

The Gibbs sampling algorithm is concisely represented in the Figure 9 as a
flowchart.
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(6.2)

Figure 9: LSBGG. flow chart representing Gibbs sampling algorithm.

Application
We apply our model to the leukemia data set of Golub et al. [32]. In the Golub
data set, the bone marrow or peripheral blood samples from 72 patients with
either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) were
collected. The gene expression levels for 7129 human genes were measured for
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this cohort. The dataset is randomly split into training group of 37 samples
containing 24 ALL samples and 13 AML samples and test group of 35 samples
containing 23 ALL and 12 AML samples. The model is trained on the train data
set and tested on the test data set and accuracy, sensitivity, and specificity of the
model is reported. We used the top 500 genes based on p-value rankings of
differentially expressed genes for downstream analysis. The literature correlation
of these genes to leukemia is obtained using GeneIndexer. GeneIndexer is a
commercially available software used to classify and prioritize genes based on
functional information in the biomedical literature. It mines for explicit and implicit
relationships, and finds an association between the genes and keywords [39].
Results
The Gibbs Sampler was run for 60k iteration and the first 20k is discarded as
burn in. Genes were ranked based on posterior mean of θ associated with each
gene. A plot of posterior mean of θ associated with genes is represented in Figure
10. Using top 5, 10, 20, 30, 40, and 50 genes obtained from the model, we

Figure 10: LSBGG. Posterior mean of θ asociated with each gene.
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evaluate classification accuracy, sensitivity and specificity on test data sets across
50 runs. The model performance was compared to the set up in which both ρj
and δj are set to 1 for all genes and no biological information was incorporated
into the model. These results are represented in Table 14. Each row represents
model performance using different numbers of genes for classification. We used,
5, 10, 20, 30, 40, and 50 genes and analyzed the model performance. The
LSBGG model outperforms the SBGG model in average accuracy, sensitivity and
specificity regardless of number of genes used for model evaluation.
Table 14: Classification Accuracy, Sensitivity, and Specificity Analysis.
#genes
5
10
20
30
40
50

Accuracy
0.93(0.054)
0.96(0.031)
0.96(0.035)
0.96(0.03)
0.97(0.03)
0.97(0.027)

LSBGG
Sensitivity
0.94(0.08)
0.97(0.039)
0.98(0.039)
0.98(0.026)
0.99(0.023)
0.99(0.021)

Specificity
0.92(0.1)
0.93(0.074)
0.93(0.081)
0.94(0.07)
0.93(0.075)
0.94(0.066)

SBGG
Accuracy
Sensitivity
0.84(0.096)
0.87(0.15)
0.89(0.08)
0.92(0.11)
0.92(0.056)
0.96(0.05)
0.94(0.042)
0.97(0.0476)
0.94(0.0408) 0.97(0.048)
0.95(0.031)
0.97(0.044)

Specificity
0.78(0.24)
0.83(0.208)
0.85(0.17)
0.89(0.12)
0.89(0.117)
0.92(0.088)

As it is obvious from the Table 14 , the model with literature informed choice of
hyper parameters results in better classification accuracy across different number
of genes chosen for classification. The classification accuracies reported are the
average results across 50 runs.
Next, we examined the top hundred genes obtained from the model across 50
runs to obtain the number of common genes and examine the consistency of
results obtained in different runs of the model. The number of common genes was
41 for our literature aided model compared to 6 for the other scenario. This results
suggest that the literature model results in more consistent gene sets based on
biologically relevant genes. This is strong indication of generalizability of the
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model for potential clinical use in diagnostics and therapeutics.
Simulation Study
In this section, we performed a simulation study with 6 different scenarios and
evaluate the performance of the literature aided model in each setting. We
simulated two different data sets of sizes 30 ( 15 cases and 15 controls) and 50
(25 cases and 25 controls). For each data set, we simulated 20 gene expression
values, assuming the first 5 genes are differentially expressed and the rest are
not. We also assumed that the first 5 genes are biologically relevant to the
response variable. Genes that are differentially expressed are randomly sampled
from N (µ1 , σ1 ) and the rest are randomly sampled from N (µ2 , σ2 ). We set
µ1 = 3, µ2 = 0, σ1 = σ2 = 1. We first elaborate on the data set with 30 samples in 3
different scenarios. We randomly divided the data into train (N=15) and
test(N=15). The model was trained on the train data set and its performance was
evaluated using the test data. The Gibbs sampling algorithm was run for 40k
iteration and the first 20k will be discarded as burn in. In the first scenario, we
assumed the first 5 genes are biologically relevant to response and the rest are
not. We put GDP distribution on gene j (j = 1, .., 20) with parameters specified as
(ρj = 1, δj = 1; j = 1, .., 5) and (ρj = 2, δj = 1; j = 6, .., 20). These two distributions
are shown in figure below. In the second scenario, we did not assume any
biological information in the model and we put GDP distribution with parameters
(ρj = 1, δj = 1; j = 1, .., 20) on parameters associated with each gene. In scenario
3, we assume the first 5 genes are biologically relevant to response variable
however these associations were mis-specified and assigned randomly (we
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randomly assign 5 genes to be our biologically relevant genes).
We randomly divided the date set into train and test samples 50 times and the
average model performance and associated standard deviations on the test
samples across 50 runs for all three scenarios are presented in Table 15. We
used different number of genes (P represents the number of genes used for
classification) in order to be able to evaluate model performance across different
number of genes for classification. As we can see, in scenario 1 in which the

Figure 11: pecification of GDP prior distributions used in simulation study.

biological relevance of genes is correctly specified and used as prior information,
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Table 15: Simulaton study: Classification Accuracy, Sensitivity, and Specificity
Analysis, N=30 (associated standard deviations are represented in parentheses) .

Scenario1
Scenario2
Scenario3

Accuracy
0.96(0.07)
0.88(0.084)
0.75(0.12)

P=5
Sensitivity
Specificity
0.94(0.08) 0.98(0.067)
0.92(0.09)
0.84(0.06)
0.68(0.095) 0.82(0.13)

P=10
Accuracy
0.98(0.055)
0.89(0.07)
0.806(0.1)

Sensitivity
0.99(0.06)
0.91(0.06)
0.75(0.076)

Specificity
0.96(0.042)
0.88(0.07)
0.87(0.08)

P=20
Accuracy
0.98(0.036)
0.92(0.06)
0.853(0.08)

Sensitivity
0.97(0.052 )
0.96(0.08)
0.905(0.11)

Specificity
0.99(0.028)
0.88(0.03)
0.8(0.063)

the model obtained highest performance. The model which does not incorporate
prior information achieved the second best performance. It is interesting to note
that when the biological relevance of markers are miss-specified, the model
performance went down. This is due to over-shrinkage imposed on true signals.
For data set with 50 samples, we use the same procedure to generate the
data set, randomly dividing the data set into 25 samples for training and 25 for
testing. We repeated scenario 1 – scenario 3. Table 16 represent the model
performance evaluation in these scenarios.
Table 16: Simulaton study: Classification Accuracy, Sensitivity, and Specificity
Analysis , N=50 (associated standard deviations are represented in parentheses).

Scenario1
Scenario2
Scenario3

Accuracy
0.93(0.07)
0.903(0.08)
0.79(0.15)

P=5
Sensitivity Specificity
0.97(0.09) 0.9(0.08)
0.87(0.10) 0.94(0.08)
0.75(0.13) 0.83(0.11)

P=10
Accuracy
0.945(0.06)
0.9(0.068)
0.81(0.09)

Sensitivity
0.92(0.08)
0.92(0.05)
0.76(0.11)

Specificity
0.97(0.03)
0.89(0.07)
0.85(0.08)

P=20
Accuracy
0.97(0.026)
0.93(0.04)
0.86(0.06)

Sensitivity
0.955(0.03)
0.91(0.05)
0.88(0.07)

Specificity
0.98(0.034)
0.954(0.04)
0.845(0.06)

Consistent with the results obtained previously, the model in which the
biological information are correctly identified and incorporated into the model
achieved higher classification accuracy, sensitivity, and specificity compared to
the model without biological information as well as the model with miss-specified
biological information. Taken together based on the simulation study, we argue
that the literature aided model with correct specification of biological information
achieves highest performance compared to the model with miss-specified
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biological information and model without use of biological information a priori.
Simulation Study part 2
In this study we added noise to the variables(gene expressions) to see how
robust the model performance is in the presence of noise. We explored several
scenarios. We add/ subtract 5, 10, 20, 30, 40, and 50 percent of the actual
variable measured to the variable as random noise. For instance, assume we
want to induce 5% noise to the data. Let xij represents gene expression value for
gene ’j’ in sample ’i’. In the new data set, we replace xij by xij ∗ U (0.95, 1.05)
where U stands for a uniform distribution. We do this procedure for all genes in
the dataset. It should be noted that we use runif function in R to generate random
uniform numbers. The Golub data set was used for this study. The biological
relevance of genes was incorporated into the model by adjusting the shape of the
GDP distribution as described in section 6.5 and figure 7. The Gibbs sampling
algorithm was run for 40k iterations and the first 20k was discarded as burn-in.
The data is devided randomly into training and test samples according to chapter
5 section 2. We performed 50 resampling on the training and test data sets. The
average classification accuracy, sensitivity, and specificity and associated
standard deviations using top 10 marker genes obtained from the model are
represented in the table 17. Based on table above, as the amount of noise in the
data increases the model accuracy decreases. However, this decrease is not
dramatic and for example the model accuracy is still above 90% in the presence
of 20% noise. This demonstrate that the methodology is reasonably robust to the
presence of noise in the system.
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Table 17: Simulaton study part 2: Average classification accuracy, Sensitivity,
Specificity and associated standard deviations (in parentheses).
5% noise
10% noise
20% noise
30% noise
40% noise
50% noise

Accuracy
Sensitivity
Specificity
0.943(0.05) 0.95(0.042) 0.927(0.062)
0.935(0.055) 0.942(0.07) 0.91(0.068)
0.903(0.07) 0.92(0.082) 0.88(0.076)
0.86(0.074)
0.84(0.06)
0.9(0.08)
0.815(0.08) 0.805(0.06)
0.842(0.1)
0.79(0.11)
0.8(0.085)
0.78(0.13)
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Chapter 7
Conclusions and Future Work
In many disciplines, such as gene expression analysis and genome-wide
association studies, values of a large number of variables are measured
simultaneously. Thus, it is very common to have a disproportionate number of
variables compared to small sample sizes. In order to highlight those variables
that are most relevant to certain phenotypes, it is necessary to develop an
approach to weed out unimportant variables. Most complex diseases are caused
by multiple effects and thus a single variable analysis can only detect a very small
portion of variation and may not be powerful enough for identifying weaker
associations [7]. In the situations that we are faced with fat datasets with p » n,
highly regularized approaches are needed to identify non-zero coefficients,
enhance model predictability and avoid over-fitting [38].
To address these limitations, we developed several Bayesian methods using
different specialized priors that impose sparsity in terms of number of variables in
the model. Using a double exponential prior on parameters we developed a
sparse model in a Generalized Linear Model framework (SBGDE). This model
can be used for classification of cancer progression stages. We evaluated the
performance of the model using a publicly available data set on prostate cancer
progression. Using the top 10 genes and top 50 genes obtained from the model
we compared average classification accuracy and class-specific classification
accuracy to well-known machine learning methods such as Support Vector

96

Machine (SVM) and Random Forest. The model outperforms SVM in all
categories and has comparable performance, albeit slightly lower, to Random
Forests. However, SBGDE identified more biologically relevant gene sets
compared to the other methods investigated.
The double exponential prior has light tails when compared to GDP that can
cause over-shrinkage of parameters towards zero, which may impose unwanted
bias. In order to address this problem, we investigated another prior distribution
with more tail robustness property. Recently, the Generalized Double Pareto
(GDP) prior distribution was proposed as an alternative to induce sparseness in
situations when we are faced with a large number of variables compared to
sample size [5]. The authors applied the proposed method in the normal linear
regression model framework. This prior has a simple analytic form, yields a
proper posterior and possesses appealing properties, including a spike at zero,
Student t-like tails, and a simple characterization as a scale mixture of normal
distributions leading to a straightforward Gibbs sampler for posterior inferences
that makes Bayesian shrinkage estimation and regularization feasible [5].
Utilizing this prior in a more general framework of generalized linear models,
we presented a sparse Bayesian hierarchical model that can incorporate a large
number of variables compared to small sample sizes. While shrinking small
effects toward zero and producing sparse solutions, the over shrinkage problem
caused by using light-tailed priors would be remedied by the heavier tails. Using
the GDP prior, we develop a sparse Bayesian generalized linear model (SBGG).
We evaluated the performance of the model using the leukemia data set of Golub
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et. al. [32]. Sensitivity, specificity, and classification accuracy measures were
used to evaluate the model. It is interesting that we found that SBGG outperforms
SBGDE and obtains higher classification accuracy and sensitivity and specificity.
We also obtained the GCAT literature p-value of top 100 genes obtained from the
model [96]. The SBGG results in more significant literature based p-values which
indicates that this model gives more biologically relevant genes compared to
SBGDE.
Additionally, we extended the SBGG model further to encompass data sets
with multi-category ordinal response. We developed a sparse Bayesian
multinomial model and evaluated its performance using prostate cancer gene
expression data. We compared the model performance to three models: Random
Forests, SVM, and SBGG. We found that the SBGG classification accuracy of
prostate cancer subtypes were comparable to Random Forrest when using 10
marker genes for classification and it outperforms Random Forest in 3 out of four
categories when we used 50 marker genes. Additionally, it outperforms SBGDE in
3 out of 4 categories when using 10 marker genes for classification and 3 out of 4
categories when using 50 marker genes. Furthermore, SBGG identified more
biologically relevant gene sets. We next asked if SBGG gene rankings were more
or less relevant to the biological mechanisms associated with prostate cancer
progression. In order to evaluate the biological relevance for the top ranked genes
in the models, we used a literature based method called GeneSet Cohesion
Analysis Tool (GCAT) [96]. GCAT is a web-based tool that determines the
functional coherence p-values of gene sets based on latent semantic analysis of
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Medline abstracts [96]. The average GCAT literature derived p-values (LPv) for the
top 100 genes obtained from 50 runs of SBGG, Random Forrest, SBGDE as well
as the top 100 genes based on the p-value rank ordering of single gene analysis
using ordinal logistic regression. We found that on average, SBGG produced
more functionally cohesive gene list (LPv = 2.0E-4) compared to SBGDE
(LPv=0.007), classical logistic regression (LPv= to 0.047) and Random Forest
(LPv=0.131). Notably, 100% of the runs had smaller LPv than 0.047, produced by
single gene analysis using classical logistic regression p-value ranking. The
Literature p-value for the median run was 4.50E-06 compared to 1.90E-04 for
SBGDE and 2.85E-02 For Random Forest. Based on these results, we posit that
SBGG may be a better approach to simultaneously identify marker genes for
classifications as well as for gaining insights into the molecular mechanisms of the
phenotype under investigation compared to the other three methods.
It is important to note that the initial gene set input to the model for the binary
and multi category situations are selected based on single gene analysis
paradigm. Hence, this could bias the initial gene selection process. Gene
selection methods that are based on signal strength and differentially expressed
genes choose genes that are highly differentially expressed across different tissue
types, i.e. cancer and normal tissue. However, most of these genes can be
housekeeping genes or genes that are differentially expressed during different cell
cycles that might not be necessarily related to cancer. It is possible that some
biologically relevant genes to the phenotype might have been missed by this
analysis due to low signal.
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Literature information can be used to select biologically relevant genes from
gene expression data in order to build cancer classifiers. These methods can be
very helpful in order to improve the biological relevance of classifiers built based
on gene expression data. Here, we investigated a very famous gene ranking
method based on biological literature called Gene Indexer [39]. Gene Indexer
utilizes Latent Semantic Indexing (LSI), a vector space model for information
retrieval, to automatically identify conceptual gene-gene and gene-disease
relationships from titles and abstracts of MEDLINE citations [39]. LSI method has
proved to identify gene-keyword and gene-gene relationships with high average
accuracy. Additionally, this method is able to obtain implicit relationships between
genes and keywords that proves very helpful in identifying conceptual
relationships [39]. The genes obtained based on literature were used for
classification using SBGG, SBGDE, SVM, and Random Forest. The results were
compared to the same models applied to input genes obtained from tests of
differential expression p-values.
For the binary response situation, we used leukemia data set for evaluating
our hypothesis. In SBGG model, the classification accuracy and sensitivity and
specificity were very close for the two paradigms. The SVM model obtained
higher classification accuracy, sensitivity, and specificity when using Gene Indexer
as input gene selection. For the Random Forest model the classification accuracy
in both paradigms are very close to each other. In conclusion, the classifiers built
on signal strength obtain higher classification accuracy compared to the Gene
Indexer input gene list counterparts.
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Next, we evaluated the literature based input gene list in the multi-category
response situations using prostate cancer progression data set [90]. The average
classification accuracy for the multi-category classifiers built on prostate cancer
progression data sets were compared. For the Benign sample type, the models
that are built based on input gene list from differential expression test outperform
the counterparts built upon input gene list obtained from Gene Indexer. For the
PIN sample type, the models based on Gene Indexer outperform their counter
parts for SBGG, SBGDE, SVM and the classification accuracy is a bit lower for
the Random Forest Model but comparable for the two scenarios. For the PCA
sample type, the models based on highly differentially expressed genes
outperform the Gene Indexer input gene list models in 3 out of four models
namely, SBGG, SBGDE, and Random Forest and it has slightly lower
classification accuracy for the SVM model. For the MET sample types, the models
based on differentially expressed input gene lists outperform all the models built
based on Gene Indexer input gene list.
Even though the classifiers built based on Gene Indexer gene selection
paradigm come close in classification accuracy, sensitivity, and specificity to their
counterparts for some of the classifiers, in the majority of the classifiers, the gene
selection based on signal strength results in higher accuracy, sensitivity, and
specificity. One of the main reasons for this phenomena is that the majority of
cancer related genes are not highly differentially expressed across different tissue
types which lowers their ability to be highly powerful predictors. On the other
hand, gene selection methods that are based on signal strength and differentially
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expressed genes, choose genes that are highly differentially expressed across
different tissue types, i.e. cancer and normal tissue. However, housekeeping
genes and genes highly differentially expressed in different cell cycles are
obtained from these methods that might not be related to cancer. Thus, the
classifiers obtained based on differentially expressed genes across different
sample types might not reveal biologically relevant genes. Even though these
models obtain higher classification accuracy, they suffer from the fact that they do
not obtain comprehensive biological relevance in the set of predictors obtained.
Using input gene list solely based on current literature biases the downstream
results due to the fact that it ignors the signals observed in the experiment.
Ideally, we would want to let signals observed have an impact on the results but
have a technique to prioritize and tune these signals based on biological
information from literature. Bridging the gap between classification accuracy and
biological relevance will be of high merit to the community and can potentially
result in deeper understanding of mechanisms involved.
In chapter 6, we developed a literature aided sparse Bayesian generalized
Linear model which utilizes Generalized Double Pareto prior (LSBGG) to induce
shrinkage in terms of number of variables. Instead of uninformed hyper
parameters for the prior distributions, we adopt a literature informed approach to
adjust the hyper parameters based on marker’s biological relevance to the
phenotype under study. This will aid us in controlling shrinkage imposed on genes
based on their biological relevance. Using the top 10 genes obtained from our
model, we were able to achieve 95.5% average classification accuracy.
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Additionally average sensitivity and specificity of 97.2% and 92.9% was achieved
across 50 runs. The model without incorporation of biological information (SBGG)
achieves average 88.6%, 91.8%, and 82.5% accuracy, sensitivity, and specificity
respectively. The LSBGG model demostrated superior performance consistently
regardless of the number of genes used for classification (Table 14). Additionally,
There were 41 genes common in all runs for the literature aided model compared
to 6 genes for the model with uninformed choice of hyper parameters. This results
suggest that the literature aided model produces more consistent results with
significantly higher biological relevance. Taken together, these results suggest
that literature informed Sparse Bayesian Generalized Linear Model applied to
leukemia data sets allows for better subclass prediction based on more
functionally relevant gene sets.
There exists a possibility of utilizing Metropolis–Hastings algorithm instead of
Griddy Gibbs sampling algorithm employed to sample hyper-parameters v, u1 , u2
in chapter 2. Metropolis Hastings is a Markov chain Monte Carlo (MCMC) method
for obtaining a sequence of random samples from a probability distribution for
which direct sampling is difficult [31]. The Metropolis–Hastings algorithm can
draw samples from any probability distribution P (x), provided you can compute
the value of a function f (x) which is close to the density of P . On the other hand,
most simple rejection sampling methods suffer from the dimensionality, where the
probability of rejection increases exponentially as a function of the number of
dimensions [31]. Metropolis Hastings algorithm is only useful when you can find a
suitable “jumping” density which is “similar” (close) to its target density to avoid
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excessively slow mixing [31]. This is a difficult task, especially for
high-dimensional space. In addition, the metropolis algorithm within each iteration
on the last part of the MCMC procedure would dramatically increase the running
time of the MCMC process.
In future, we plan to extensively investigate the LSBGG model performance
across several different cancer cohorts. Additionally, we plan to investigate the
possible development of an effective model to translate biological information to
choice of hyper parameters. Furthermore, it is possible to evaluate performance
of models developed using pathway driven feature selection methods while
considering more complex variance-covariance matrix structures which takes into
account gene-gene interactions. In addition to these potentially exciting new
developments, further development is possible by considering survival time data
frameworks.
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Appendix
Here,1we derive fully conditional posterior distribution of parameter for the
models in chapter 2, chapter 4, and chapter 6. In these chapters Generalized
Double Pareto Prior is utilized for impossing sparsity in the models.
Derivation of transformations used on parameters ρ and δ
Let ρ and δ have the following distributions.

π(ρ) =

c
;c > 0
(1 + cρ)2

π(δ) =

c0
0
2;c > 0
0
(1 + c δ)

Define the new variables u1 and u2 as follows:

u1 =

1
;
1 + cρ

u2 =

1
1 + c0 δ

Using simple inverse method technique we can see that u1 and u2 are uniformly
distributed. Here, we show the process for u1 .
F (ρ) =

1
1+cρ

is the cdf of the pdf π(ρ) =

c
.
(1+cρ)2

We know that for Y = F (X) has

a U (0, 1).
SBGG: Deriving fully conditional distributions for parameters used in Gibbs
sampling.
Let the matrices Λ and T ∗ be diagonal matrices define as defined as
Λ = diag(Λ1 , · · · , Λn ) and T ∗ = diag(τ1−1 , ...τp−1 ) . Using the prior specifications in
chapter 2, we obtain the following joint distribution.
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2
2
(2)
h
 P
i
 P

i hQ
p
p
p
ρ−1
2
exp −1
∗
exp
−δ
λ
∗ π(u1 ) ∗ π(u2 )
λ
τ
∗
λ
j=1 j
j=1 j j
j=1 j
2
i=1

Now we need to obtain fully conditional distributions for all the parameter in the
model. In what follows, in each subsection we derive these fully conditional
distributions step by step.

Fully Conditional Posterior Distribution for θ
It can be seen that the fully conditional distribution on θ is proportional to the
following.
hQ
i
Λi ∗(li −wiT θ)2
n
θ|− ∝
) ∗ exp
i=1 exp(
−2

−1 T ∗
θ T θ
2



Next, we show that this fully conditional distribution is multivariate normal and
obtain the corresponding mean vector and variance covariance matrix needed in
order to be able to sample these parameters in each iteration of Gibbs sampling.
θ|− ∝ exp

Pn

1
i=1 −2 (li

−1 T ∗
θ T θ
2

1
−2

h
i
T
T ∗
(L − W θ) Λ (L − W θ)) + (θ T θ)

θ|− ∝ exp

1
−2



LT ΛL − 2θ T W T ΛL + θ T W T ΛW θ + θ T T ∗ θ

θ|− ∝ exp

1
−2



θ T (W T ΛW + T ∗ )θ − 2θ T W T ΛL

θ|− ∝ exp




− wiT θ)T Λi (li − wiT θ) ∗ exp

θ|− ∝

h
T
1
θ − (W T ΛW + T ∗ )−1 W T ΛL
exp −2

T







W ΛW + T

∗



 i
θ − (W ΛW + T ) W ΛL
T

Therefore, the Fully conditional distribution on θ ismultivariate normal
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∗ −1

T

distribution with following specification.
h
−1 T
W ΛL ,
θ|− ∼ M W N
W T ΛW + T ∗

T

W ΛW + T


∗ −1

i

Fully Conditional Posterior for τj
Before delving into derivation of fully conditional posterior for τj , we introduce
inverse Gaussian distribution for matter of consistancy. Let
x ∼ Inv − Gaussian(µ, σ). The pdf of x is defined as follows.



h σ i 12
−σ(x − µ)2
f (x) =
∗ exp
2πx3
2µ2 x

based on the joint distribution demonstrated early in this appendix, the fully
conditional posterior for τj is proportional to the following.
i
h  θ2
τj |− ∝ 11 ∗ exp − 12 τjj + λ2j τj
τj2

In order to be able to effectively sample τj in each iteration of Gibbs sampling,
we need to obtain the closed form of the distribution and obtain the equations
defining mean and variance of this distribution. In what follows, the details of the
process taken is explained step by step.
1
τj

Let K =
g(k) =
g(k) ∝
g(k) ∝

then we have:

f ( k1 )
1
3

k2
1
3

k2

∗

1
k2

h

1

∝ −1 ∗ exp
k 2
h
i
λ2
∗ exp − 12 (kθj2 + kj )
h  θ2 k2 +λ2 i
∗ exp − 12 j k j

 λ2 
k2 +

g(k) ∝

1
3

k2

2

θ
− 12 ( 1j
k

∗ exp − 12 θj2 

k

+

λ2j

∗

i

1
)
k

j
θ2
j
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1
k2


g(k) ∝

1
3

k2



k2 +

∗ exp − 12 θj2 

g(k) ∝

3
k2

λ2
j
θ2
J

g(k) ∝

3
k2

 1 2 (k−
∗ exp 
− 2 θj

g(k) ∝

1
3

k2



∗ exp −λ2j


2









k−

λ2
j
θ2
J

k−

! 1 2
2
 






λ2
k∗ 2j
θ
j

λ2
j
θ2
J

! 1 2
2
 






λ2
2 2j ∗k
θ
j

 λ2  12



τj−1 |−



)2

k


 λ2 

∗ exp − 12 θj2 θ2j
j



2kλj
θj



!1


1

+

k


1

λ2
2kλ
j
− θ j
θ2
j
j

j
θj2

∼ Inv − Gaussian µ =
, σ=
r


λ2
τj−1 |− ∼ Inv − Gaussian µ = θ2j , σ = λ2j
k|− =

λ2j



j

Fully Conditiona Posteriorl Distribution for λj
Here, we show that fully conditional distribution on λj is gamma distribtution and
obtain the parameters associated with it.
π(τj , λj |−) = π(τj |λj , −) ∗ π(λj |−)
i
h  θ2
λj
j
1
2
∗ λρ+1−1
exp (−δλj )
π(τj , λj |−) ∝ 1 ∗ exp − 2 τj + λj τj
j
τj2

π(τj , λj |−) ∝
 
h
i
 2  1 
2
θj2
λj
1
2
2 λj 12
2 λj 2
)
τ
−
2θ
∗ λρ+1−1
exp [−δλj ]
+
λ
∗
exp
−θ
(
1 ∗ exp − 2
2
2
j
j
j
j θ
j
τj
θ
τj2

π(λj |−) =

j

j

π(τj ,λj |−)
π(τj |λj ,−)

Using the kernel obtained for π(τj |λj , −) in previous section we obtain:
i
h
|λj |
2
π(λj |−) ∝ exp −θj ∗ |θj | ∗ λjρ+1−1 exp [−δλj ]
h
i
λ
π(λj |−) ∝ exp −θj2 ∗ |θjj| − δλj ∗ λjρ+1−1
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π(λj |−) ∝ exp [−λj (|θj | + δ)] ∗ λρ+1−1
j
λj |− ∼ Gamma (ρ + 1, |θj | + δ)

Fully Conditional Distribution for Λr
It can be easily seen that the fully conditional distribution on ΛJ is gamma
distributions and the parameters associated with it are specified below.
h
i
v
1


T 2
−1
Λr |− ∝ Λr2 exp − (lr −w2 r θ) ∗ Λr ∗ Λr2 exp − v2 Λr
Λr |− ∼ Gamma

 v+1
2

, 12 ∗ (lr − wrT θ)2 + v



The Fully Conditional Distributions for u1 , and u2
Having each θj GDP ( ρδ , ρ) independently, the joint distribution of θs is as


−(1+ρ) 
Qp
|θj |
1
follows: π(θ) = j=1 2 δ ∗ 1 + δ
ρ

We put prior distributions as defined in equations (2.7) and equation (2.8).
Transformations defined in equation (2.9) is used which results in uniform priors
for new variables u1 andu2 . Using the results from [5] the following posterior
distributions are obtained for u1 and u2 .
−( 1−u
p Q 

1 +1)
cu1
|θj |
p
1
u1 |− ∝ 1−u
∗
1
+
j=1
cu1
δ
 0 p Q 
−(1+ρ)
p
c u2
c0 u2
u2 |− ∝ 1−u2 ∗ j=1 1 + 1−u2 |θj |
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AppendixDeriving
2
SBGDE:
fully conditional distributions for parameters used in Gibbs
sampling.
The fully conditional distributions for the Sparse Bayesian model developed
using double exponential prior developed in chapter3 are explored in this
appendix. Let T be a diagonal matrix defined as T = diag(η1 , · · · , ηp ).
Using the prior distributions as defined in chapter 3, we obtain the following
joint distribution.
π(θ, l|y) ∝
hQ

p
1
j=1 √ηj

i

i


(li −wiT θ)2
∗
j=1 [I(yi = j) ∗ I(γj < li ≤ γj+1 ) exp
−2

hP
k

Qn

i=1

∗ exp

−1 T −1
θ T θ
2



∗ exp



− λ2

Pp

j=1

ηj



Fully Conditional Posterior Distribution for model parameters θ
based on the joint distribution obtained above, the fully conditional distribution on
θ is as follows.
θ|Ω ∝

hQ

n
i=1

exp(

(li −wiT θ)2
)
−2

i

∗ exp

−1 T ∗
θ T θ
2



We need to obtain closed form for this fully conditional distribution and obtain the
mean parameter and variance covariance matrix associated with it.
θ|Ω ∝ exp
θ|Ω ∝ exp
θ|Ω ∝ exp

Pn

1
i=1 −2 (li

1
[(L
−2

1
[
−2


− wiT θ)T (li − wiT θ) ∗ exp

−1 T ∗
θ T θ
2




− W θ)T (L − W θ) + (θ T T ∗ θ)]

LT L − 2θ T W T L + θ T W T W θ + θ T T −1 θ ]
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θ|Ω ∝ exp

1
[
−2

θ T (W T W + T −1 )θ − 2θ T W T L ]



θ|Ω ∝
exp − 12 [θ − (W T W + T −1 )−1 W T L]T (W T W + T −1 )[θ − (W T W + T −1 )−1 W T L]



Based on these results, the fully conditional distribution on parameters θ is
multivariate normal distribution with parameters specifications as defined below.
θ|Ω ∼ M W N



(W T W + T −1 )−1 W T L , (W T W + T −1 )−1



Fully Conditional Posterior for ηj
ηj |Ω ∝

i
h
θ2
∗ exp − 12 ( ηjj + λ2j ηj )

1
1
ηj2

We need to obtain closed form of the fully conditional distribution on ηj in order to
be able to sample these parameters efficiently in each iteration of Gibbs sampling.
Let Z =

1
ηj

then we have:

G(z) = P (Z ≤ z) = P ( η1j ≤ z) = P (ηj ≥ z1 ) = 1 − F ( z1 )
g(z) = f ( z1 ) ∗
g(z) ∝

1
3

z2

1
z2

h
i
z 2 θ2 +λ
∗ exp − 12 ( zj )
"
#
λ
2
z +

g(z) ∝
g(z) ∝
g(z) ∝

1
3
z2

1
3

z2
1
3

z2

∗ exp − 12 θj2 (
"
∗ exp − 12 θj2 (

z
z2 +

θ2
j

)

λ
− 2zλ
+ 2zλ
θj
θj
θ2
j

z

#
)

√


(z− |θ λ| )2
j
1 2
∗ exp − 2 θj
z

120

√

"
g(z) ∝

1
3

z2

∗ exp − 12 θj2 ∗

z|Ω ∝ Inv − Gaussian

λ
θj2

√

(z− |θ λ| )2

#

j
λ
θ2
j

z



λ
,λ
|θj |

Fully Conditional Distributions for γs
γs |Ω ∝

Qn

i=1

[I(yi = s − 1) ∗ I(γs−1 ≤ li < γs ) + I(yi = s) ∗ I(γs ≤ li < γs+1 )]

Using equation 3.2, and 3.10, and based on the results in [1], the conditional
posterior distribution of γs can be seen to be U nif orm(δ1 , δ2 ) in which
δ1 = max [maxi [li |yi = s − 1], γs−1 ] and δ2 = min [mini [li |yi = s], γs ]. It should be
noted that I() is indicator function and its value is one if its argument is true and is
zero otherwise [1]. This argument is based on the results presented in [1].
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